<PAGE>

================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                    FORM 10-Q

(Mark One)

[X]      Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934

                For the quarterly period ended September 30, 2007; or

[ ]      Transition Report Pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934 for the transition period from _______ to _______

                         Commission File Number 0-23511

                                ----------------

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                NEVADA                                  87-0573331
    (STATE OR OTHER JURISDICTION OF         (I.R.S. EMPLOYER IDENTIFICATION NO.)
     INCORPORATION OR ORGANIZATION)

       1301 NORTH TUSTIN AVENUE
        SANTA ANA, CALIFORNIA                              92705
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)                 (ZIP CODE)

                                 (714) 953-3503
              (Registrant's telephone number, including area code)


              (Former name, former address and former fiscal year,
                          if changed since last report)

                                ----------------

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an
accelerated filer, or a non-accelerated filer. See definition of "accelerated
filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check
one):

Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [X]

Indicate by check mark whether the  registrant is a shell company (as defined in
Rule 12b-2 of the Act). Yes [ ] No [X]

There were 137,095,716 shares outstanding of the registrant's common stock as of
September 30, 2007.

================================================================================





<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
                                    FORM 10-Q

                                TABLE OF CONTENTS


                                                                            Page
                                                                            ----


         PART I - FINANCIAL INFORMATION


Item 1.  Financial Statements:

         Condensed Consolidated Balance Sheets as of September 30, 2007
           and March 31, 2007 - (unaudited)                                   3

         Condensed Consolidated Statements of Operations for the three
           and six months ended September 30, 2007 and 2006, as
           restated - (unaudited)                                             4

         Condensed Consolidated Statements of Cash Flows for the six
           months ended September 30, 2007 and 2006, as restated -
           (unaudited)                                                        5

         Notes to Condensed Consolidated Financial Statements -
           (unaudited)                                                        6

Item 2.  Management's Discussion and Analysis of Financial Condition
           and Results of Operations                                         28

Item 3.  Quantitative and Qualitative Disclosures About Market Risk          42

Item 4.  Controls and Procedures                                             42

         PART II - OTHER INFORMATION

Item 1.  Legal Proceedings                                                   42

Item 1A. Risk Factors                                                        44

Item 6.  Exhibits                                                            45

         Signatures                                                          46


                                       2




<PAGE>
<TABLE>

PART I - FINANCIAL INFORMATION

                                      INTEGRATED HEALTHCARE HOLDINGS, INC.
                                     CONDENSED CONSOLIDATED BALANCE SHEETS
                                      (amounts in 000's, except par value)
                                                  (unaudited)


                                                                                SEPTEMBER 30,      MARCH 31,
                                                                                    2007             2007
                                                                                -------------   -------------
<S>                                                                             <C>             <C>
                                                     ASSETS
Current assets:
    Cash and cash equivalents                                                   $       1,470   $       7,844
    Restricted cash                                                                        20           4,968
    Accounts receivable, net of allowance for doubtful
        accounts of $1,822 and $2,355, respectively                                    21,466          19,370
    Security reserve funds                                                             18,332           7,990
    Deferred purchase price receivable                                                 12,543          16,975
    Inventories of supplies                                                             5,918           5,944
    Due from governmental payers                                                        7,557           1,378
    Prepaid expenses and other current assets                                           9,134           8,097
                                                                                -------------   -------------
                  Total current assets                                                 76,440          72,566

Property and equipment, net                                                            56,951          58,172
Other assets                                                                              325               -
                                                                                -------------   -------------
                  Total assets                                                  $     133,716   $     130,738
                                                                                =============   =============

                                    LIABILITIES AND STOCKHOLDERS' DEFICIENCY

Current liabilities:
    Debt, current                                                               $      72,341   $      72,341
    Accounts payable                                                                   47,677          41,443
    Accrued compensation and benefits                                                  13,392          12,574
    Warrant liability, current                                                         10,700          14,906
    Due to governmental payers                                                          1,903             922
    Other current liabilities                                                          20,011          20,687
                                                                                -------------   -------------
                  Total current liabilities                                           166,024         162,873

Capital lease obligations, net of current portion
    of $264 and $251, respectively                                                      5,706           5,834
Minority interest in variable interest entity                                           1,480           1,716
                                                                                -------------   -------------
                  Total liabilities                                                   173,210         170,423
                                                                                -------------   -------------

Commitments, contingencies and subsequent events

Stockholders' deficiency:
    Common stock, $0.001 par value; 250,000 shares authorized;
        137,096 and 116,304 shares issued and outstanding, respectively                   137             116
    Additional paid in capital                                                         30,408          25,589
    Accumulated deficit                                                               (70,039)        (65,390)
                                                                                -------------   -------------
                  Total stockholders' deficiency                                      (39,494)        (39,685)

                                                                                -------------   -------------
                  Total liabilities and stockholders' deficiency                $     133,716   $     130,738
                                                                                =============   =============


  THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.


                                                       3





<PAGE>

                                             INTEGRATED HEALTHCARE HOLDINGS, INC.
                                        CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                         (amounts in 000's, except per share amounts)
                                                          (unaudited)


                                                       THREE MONTHS ENDED SEPTEMBER 30,      SIX MONTHS ENDED SEPTEMBER 30,
                                                       --------------------------------     --------------------------------
                                                           2007                2006             2007                2006
                                                       ------------        ------------     ------------        ------------
                                                                            (restated)                           (restated)

Net operating revenues                                 $     95,376        $     85,343     $    182,168        $    176,335
                                                       ------------        ------------     ------------        ------------

Operating expenses:
     Salaries and benefits                                   51,122              48,467           99,951              95,427
     Supplies                                                12,277              12,325           24,580              24,353
     Provision for doubtful accounts                          7,353               9,167           15,584              18,840
     Other operating expenses                                17,323              16,662           34,180              35,017
     Loss on sale of accounts receivable                      2,411               2,630            4,997               4,969
     Depreciation and amortization                              800                 655            1,593               1,325
                                                       ------------        ------------     ------------        ------------
                                                             91,286              89,906          180,885             179,931
                                                       ------------        ------------     ------------        ------------

Operating income (loss)                                       4,090              (4,563)           1,283              (3,596)
                                                       ------------        ------------     ------------        ------------

Other income (expense):
     Interest expense, net                                   (3,081)             (3,407)          (6,168)             (6,653)
     Change in fair value of derivative                           -                 779                -               5,104
                                                       ------------        ------------     ------------        ------------
                                                             (3,081)             (2,628)          (6,168)             (1,549)
                                                       ------------        ------------     ------------        ------------

Income (loss) before provision for income
   taxes and minority interest                                1,009              (7,191)          (4,885)             (5,145)
     Provision for income taxes                                   -                   -                -                   -
     Minority interest in variable interest entity              117                 187              236                 329
                                                       ------------        ------------     ------------        ------------

Net income (loss)                                      $      1,126        $     (7,004)    $     (4,649)       $     (4,816)
                                                       ============        ============     ============        ============
Per Share Data:
   Income (loss) per common share
     Basic                                                    $0.01              ($0.08)          ($0.04)             ($0.06)
     Diluted                                                  $0.01              ($0.08)          ($0.04)             ($0.06)
   Weighted average shares outstanding
     Basic                                                  136,870              85,013          126,643              84,684
     Diluted                                                190,370              85,013          126,643              84,684


         THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.


                                                              4





<PAGE>

                                       INTEGRATED HEALTHCARE HOLDINGS, INC.
                                  CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                (amounts in 000's)
                                                    (unaudited)


                                                                              SIX MONTHS ENDED SEPTEMBER 30,
                                                                        -----------------------------------------
                                                                               2007                   2006
                                                                        ------------------     ------------------
                                                                                                   (restated)
Cash flows from operating activities:
Net loss                                                                 $         (4,649)       $        (4,816)
Adjustments to reconcile net loss to net cash
      provided by (used in) operating activities:
      Depreciation and amortization of property and equipment                       1,593                  1,325
      Provision for doubtful accounts                                              15,584                  9,673
      Amortization of debt issuance costs and intangible assets                         -                    483
      Change in fair value of derivative                                                -                 (5,103)
      Minority interest in net loss of variable interest entity                      (236)                  (409)
      Noncash share-based compensation expense                                         58                      -
Changes in operating assets and liabilities:
      Accounts receivable                                                         (17,680)               (11,872)
      Security reserve funds                                                      (10,342)                 8,610
      Deferred purchase price receivables                                           4,432                 (4,695)
      Inventories of supplies                                                          26                    148
      Due from governmental payers                                                 (6,179)                (1,127)
      Prepaid expenses, other current assets, and other assets                     (1,363)                 1,446
      Accounts payable                                                              6,234                  3,409
      Accrued compensation and benefits                                               818                    467
      Due to governmental payers                                                      981                  1,952
      Other current liabilities                                                      (675)                (1,478)
                                                                        ------------------     ------------------
        Net cash used in operating activities                                     (11,398)                (1,987)
                                                                        ------------------     ------------------

Cash flows from investing activities:
      Decrease in restricted cash                                                   4,948                      -
      Additions to property and equipment                                            (372)                  (164)
                                                                        ------------------     ------------------
        Net cash provided by (used in) investing activities                         4,576                   (164)
                                                                        ------------------     ------------------

Cash flows from financing activities:
      Proceeds from long term debt                                                      -                  2,000
      Issuance of common stock                                                        576                      -
      Variable interest entity distribution                                             -                   (180)
      Payments on capital lease obligations                                          (128)                   (48)
                                                                        ------------------     ------------------
        Net cash provided by financing activities                                     448                  1,772
                                                                        ------------------     ------------------

Net decrease in cash and cash equivalents                                          (6,374)                  (379)
Cash and cash equivalents, beginning of period                                      7,844                  4,970
                                                                        ------------------     ------------------
Cash and cash equivalents, end of period                                 $          1,470        $         4,591
                                                                        ==================     ==================


    THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.


                                                         5
</TABLE>





<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)


NOTE 1 - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

      The accompanying unaudited condensed consolidated financial statements
have been prepared in conformity with generally accepted accounting principles
in the United States of America ("U.S. GAAP")for interim consolidated financial
information and with the instructions for Form 10-Q and Article 10 of Regulation
S-X. In accordance with the instructions and regulations of the Securities and
Exchange Commission ("SEC") for interim reports, certain information and
footnote disclosures normally included in financial statements prepared in
conformity with U.S. GAAP for annual reports have been omitted or condensed.

      The accompanying unaudited condensed consolidated financial statements for
Integrated Healthcare Holdings, Inc. and its subsidiaries (the "Company")
contain all adjustments, consisting only of normal recurring adjustments,
necessary to present fairly the Company's consolidated financial position as of
September 30, 2007, its results of operations for the three and six months ended
September 30, 2007 and 2006, as restated, and its cash flows for the six months
ended September 30, 2007 and 2006, as restated.

      The results of operations for the three and six months ended September 30,
2007 are not necessarily indicative of the results to be expected for the full
year. The information included in this Quarterly Report on Form 10-Q should be
read in conjunction with the audited consolidated financial statements for the
year ended March 31, 2007 and notes thereto included in the Company's Annual
Report on Form 10-K filed with the SEC on July 16, 2007.

      LIQUIDITY AND MANAGEMENT'S PLANS - The accompanying unaudited condensed
consolidated financial statements have been prepared on a going concern basis,
which contemplates the realization of assets and settlement of obligations in
the normal course of business. The Company incurred a net loss (in thousands) of
$4,649 for the six months ended September 30, 2007 and has a working capital
deficit (in thousands) of $89,584 at September 30, 2007. All of the Company's
debt matured on June 30, 2007. The Company, however, refinanced its outstanding
debt in October 2007 (Note 11).

      Not withstanding the refinancing, these factors, among others, indicate a
need for the Company to take action to operate its business as a going concern.
In the Company's Annual Report for the year ended March 31, 2007, its
independent registered public accountants expressed a substantial doubt about
the Company's ability to continue as a going concern. The Company has received
increased reimbursements from governmental payers over the past year and is
aggressively seeking to obtain future increases. The Company is seeking to
reduce operating expenses while continuing to maintain service levels. There can
be no assurance that the Company will be successful in improving reimbursements
or reducing operating expenses.

      DESCRIPTION OF BUSINESS - The Company was organized under the laws of the
State of Utah on July 31, 1984 under the name of Aquachlor Marketing. Aquachlor
Marketing never engaged in business activities. In December 1988, Aquachlor
Marketing merged with Aquachlor, Inc., a Nevada corporation incorporated on
December 20, 1988. The Nevada Corporation became the surviving entity and
changed its name to Deltavision, Inc. In March 1997, Deltavision, Inc. received
a Certificate of Revival from the State of Nevada using the name First
Deltavision, Inc. In March 2004, First Deltavision, Inc. changed its name to
Integrated Healthcare Holdings, Inc. In these consolidated financial statements,
the Company refers to Integrated Healthcare Holdings, Inc. and its subsidiaries.

      Prior to March 8, 2005, the Company was a development stage enterprise
with no material operations and no revenues from operations. On September 29,
2004, the Company entered into a definitive agreement to acquire four hospitals
(the "Hospitals") from subsidiaries of Tenet Healthcare Corporation ("Tenet"),
and completed the transaction on March 8, 2005 (the "Acquisition"). The
Hospitals are:

      o     282-bed Western Medical Center in Santa Ana, California;
      o     188-bed Western Medical Center in Anaheim, California;
      o     178-bed Coastal Communities Hospital in Santa Ana, California; and
      o     114-bed Chapman Medical Center in Orange, California.


                                       6




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)


      The Company enters into agreements with third-party payers, including
government programs and managed care health plans, under which rates are based
upon established charges, the cost of providing services, predetermined rates
per diagnosis, fixed per diem rates or discounts from established charges.
During the 24 days ended March 31, 2005, substantially all of Tenet's negotiated
rate agreements were assigned to the Hospitals. The Company received Medicare
provider numbers in April 2005 and California State Medicaid Program provider
numbers were received in June 2005.

      RESTATEMENT - As described more fully in the Company's annual report on
Form 10-K for the year ended March 31, 2007, the statements of operations for
the three and six months ended September 30, 2006 and the statement of cash
flows for the six months ended September 30, 2006 have been restated.

      RECLASSIFICATION FOR PRESENTATION - Certain amounts previously reported
have been reclassified to conform to the current period's presentation.

      CONCENTRATION OF CREDIT RISK - The Company secures all of its working
capital from the sale of accounts receivable and obtained all of its debt from
affiliates of Medical Capital Corporation and, thus, is subject to significant
credit risk if they are unable to perform. In October 2007, the Company
reacquired all previously sold receivables (Note 11).

      The Hospitals are subject to licensure by the State of California and
accreditation by the Joint Commission on Accreditation of Healthcare
Organizations. Loss of either licensure or accreditation would impact the
ability to participate in various governmental and managed care programs, which
provide the majority of the Company's revenues.

      Essentially all net operating revenues come from external customers. The
largest payers are the Medicare and Medicaid programs accounting for 68% and 63%
of the net operating revenues for the three months ended September 30, 2007 and
2006, respectively, and 66% and 69% for the six months ended September 30, 2007
and 2006, respectively. No other payers represent a significant concentration of
the Company's net operating revenues.

      CONSOLIDATION - The accompanying condensed consolidated financial
statements include the accounts of the Company and its wholly owned
subsidiaries.

      The Company has also determined that Pacific Coast Holdings Investment,
LLC ("PCHI") (Note 9), is a variable interest entity as defined in Financial
Accounting Standards Board ("FASB") Interpretation Number ("FIN") No. 46R, and,
accordingly, the financial statements of PCHI are included in the accompanying
condensed consolidated financial statements.

      All significant intercompany accounts and transactions have been
eliminated in consolidation.

      USE OF ESTIMATES - The accompanying condensed consolidated financial
statements have been prepared in accordance with U.S. GAAP and prevailing
practices for investor owned entities within the healthcare industry. The
preparation of financial statements in conformity with U.S. GAAP requires
management to make estimates and assumptions that affect the amounts reported in
the consolidated financial statements and accompanying notes. Management
regularly evaluates the accounting policies and estimates that are used. In
general, management bases the estimates on historical experience and on
assumptions that it believes to be reasonable given the particular circumstances
in which its Hospitals operate. Although management believes that all
adjustments considered necessary for fair presentation have been included,
actual results may materially vary from those estimates.

      REVENUE RECOGNITION - Net operating revenues are recognized in the period
in which services are performed and are recorded based on established billing
rates (gross charges) less estimated discounts for contractual allowances,
principally for patients covered by Medicare, Medicaid, managed care and other
health plans. Gross charges are retail charges. They are not the same as actual
pricing, and they generally do not reflect what a hospital is ultimately paid
and therefore are not displayed in the condensed consolidated statements of
operations. Hospitals are typically paid amounts that are negotiated with
insurance companies or are set by the government. Gross charges are used to
calculate Medicare outlier payments and to determine certain elements of payment
under managed care contracts (such as stop-loss payments). Because Medicare
requires that a hospital's gross charges be the same for all patients
(regardless of payer category), gross charges are also what Hospitals charge all
other patients prior to the application of discounts and allowances.


                                       7





<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)


      Revenues under the traditional fee-for-service Medicare and Medicaid
programs are based primarily on prospective payment systems. Discounts for
retrospectively cost based revenues and certain other payments, which are based
on the Hospitals' cost reports, are estimated using historical trends and
current factors. Cost report settlements for retrospectively cost-based revenues
under these programs are subject to audit and administrative and judicial
review, which can take several years until final settlement of such matters are
determined and completely resolved. Estimates of settlement receivables or
payables related to a specific year are updated periodically and at year end and
at the time the cost report is filed with the fiscal intermediary. Typically no
further updates are made to the estimates until the final Notice of Program
Reimbursement is received, at which time the cost report for that year has been
audited by the fiscal intermediary. There could be a one to two year time lag
between the submission of a cost report and receipt of the Final Notice of
Program Reimbursement. Since the laws, regulations, instructions and rule
interpretations governing Medicare and Medicaid reimbursement are complex and
change frequently, the estimates recorded by the Hospitals could change by
material amounts. The Company has established settlement payables as of
September 30, 2007 (in thousands) of $305 and receivables as of March 31, 2007
(in thousands) of $909.

      Outlier payments, which were established by Congress as part of the
diagnosis-related groups ("DRG") prospective payment system, are additional
payments made to Hospitals for treating Medicare patients who are costlier to
treat than the average patient in the same DRG. To qualify as a cost outlier, a
hospital's billed (or gross) charges, adjusted to cost, must exceed the payment
rate for the DRG by a fixed threshold established annually by the Centers for
Medicare and Medicaid Services of the United States Department of Health and
Human Services ("CMS"). Under Sections 1886(d) and 1886(g) of the Social
Security Act, CMS must project aggregate annual outlier payments to all
prospective payment system Hospitals to be not less than 5% or more than 6% of
total DRG payments ("Outlier Percentage"). The Outlier Percentage is determined
by dividing total outlier payments by the sum of DRG and outlier payments. CMS
annually adjusts the fixed threshold to bring expected outlier payments within
the mandated limit. A change to the fixed threshold affects total outlier
payments by changing (1) the number of cases that qualify for outlier payments,
and (2) the dollar amount Hospitals receive for those cases that still qualify.
The most recent change to the cost outlier threshold that became effective on
October 1, 2006 was an increase from $23.6 thousand to $24.485 thousand. CMS
projects this will result in an Outlier Percentage that is approximately 5.1% of
total payments. The Medicare fiscal intermediary calculates the cost of a claim
by multiplying the billed charges by the cost-to-charge ratio from the
hospital's most recent filed cost report.

      The Hospitals received new provider numbers in 2005 and, because there was
no specific history, the Hospitals were reimbursed for outliers based on
published statewide averages. If the computed cost exceeds the sum of the DRG
payment plus the fixed threshold, the hospital receives 80% of the difference as
an outlier payment. Medicare has reserved the option of adjusting outlier
payments, through the cost report, to the hospital's actual cost-to-charge
ratio. Upon receipt of the current payment cost-to-charge ratios from the fiscal
intermediary, any variance between current payments and the estimated final
outlier settlement are examined by the Medicare fiscal intermediary. The Company
recorded $755.4 thousand in Final Notice of Program Reimbursement settlements
during the three and six months ended September 30, 2007. There were no
adjustments for Final Notice of Program Reimbursement received during the three
and six months ended September 30, 2006. As of September 30 and March 31, 2007,
the Company recorded reserves for excess outlier payments due to the difference
between the Hospitals actual cost to charge rates and the statewide average in
the amount (in thousands) of $1,598 and $1,831, respectively. These reserves are
combined with third party settlement estimates and are included in due to
government payers as a net payable (in thousands) of $1,903 and $922 as of
September 30, and March 31, 2007, respectively.

      The Hospitals receive supplemental payments from the State of California
to support indigent care (MediCal Disproportionate Share Hospital payments or
"DSH") and from the California Medical Assistance Commission ("CMAC"). The
Hospitals received supplemental payments (in thousands) of $74 and $3,500 during
the three months ended September 30, 2007 and 2006, respectively, and
supplemental payments (in thousands) of $3,828 and $12,136 during the six months
ended September 30, 2007 and 2006, respectively. The related revenue recorded
for the three months ended September 30, 2007 and 2006 was (in thousands) $6,511
and $4,241, respectively, and $10,007 and $11,985 for the six months ended
September 30, 2007 and 2006, respectively. As of September 30 and March 31,
2007, estimated DSH receivables (in thousands) of $7,557 and $1,378 are included
in due from governmental payers in the accompanying condensed consolidated
balance sheets.


                                       8

<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

      The following is a summary of due from and due to governmental payers as
of September 30 and March 31, 2007:

                                                 September 30,     March 31,
                                                     2007            2007
                                                 ------------    ------------

Due from government payers
        DSH and CMAC supplemental receivable     $      7,557    $      1,378
                                                 ------------    ------------
                                                 $      7,557    $      1,378
                                                 ============    ============

Due to government payers
        Medicare and Medicaid                    $        305    $       (909)
        Outlier                                         1,598           1,831
                                                 ------------    ------------
                                                 $      1,903    $        922
                                                 ============    ============

      Revenues under managed care plans are based primarily on payment terms
involving predetermined rates per diagnosis, per-diem rates, discounted
fee-for-service rates and/or other similar contractual arrangements. These
revenues are also subject to review and possible audit by the payers. The payers
are billed for patient services on an individual patient basis. An individual
patient's bill is subject to adjustment on a patient-by-patient basis in the
ordinary course of business by the payers following their review and
adjudication of each particular bill. The Hospitals estimate the discounts for
contractual allowances utilizing billing data on an individual patient basis. At
the end of each month, the Hospitals estimate expected reimbursement for
patients of managed care plans based on the applicable contract terms. These
estimates are continuously reviewed for accuracy by taking into consideration
known contract terms as well as payment history. Although the Hospitals do not
separately accumulate and disclose the aggregate amount of adjustments to the
estimated reimbursements for every patient bill, management believes the
estimation and review process allows for timely identification of instances
where such estimates need to be revised. The Company does not believe there were
any adjustments to estimates of individual patient bills that were material to
its net operating revenues.

      The Hospitals provide charity care to patients whose income level is below
300% of the Federal Poverty Level. Patients with income levels between 300% and
350% of the Federal Poverty Level qualify to pay a discounted rate under AB774
based on various government program reimbursement levels. Patients without
insurance are offered assistance in applying for Medicaid and other programs
they may be eligible for, such as state disability, Victims of Crime, or county
indigent programs. Patient advocates from the Hospitals' Medical Eligibility
Program ("MEP") screen patients in the hospital and determine potential linkage
to financial assistance programs. They also expedite the process of applying for
these government programs. Based on average revenue for comparable services from
all other payers, revenues foregone under the charity policy, including indigent
care accounts, were $2.0 million and $2.0 million for the three months ended
September 30, 2007 and 2006, respectively, and $3.6 million and $4.5 million for
the six months ended September 30, 2007 and 2006, respectively.

      Receivables from patients who are potentially eligible for Medicaid are
classified as Medicaid pending under the MEP, with appropriate contractual
allowances recorded. If the patient does not qualify for Medicaid, the
receivables are reclassified to charity care and written off, or they are
reclassified to self-pay and adjusted to their net realizable value through the
provision for doubtful accounts. Reclassifications of Medicaid pending accounts
to self-pay do not typically have a material impact on the results of operations
as the estimated Medicaid contractual allowances initially recorded are not
materially different than the estimated provision for doubtful accounts recorded
when the accounts are reclassified. All accounts classified as pending Medicaid,
as well as certain other governmental receivables, over the age of 180 days were
fully reserved in contractual allowances as of March 31, 2007. In June 2007, the
Company evaluated its historical experience and changed to a graduated reserve
percentage based on the age of governmental accounts. The impact of the change
was not material.

      The Company is not aware of any material claims, disputes, or unsettled
matters with any payers that would affect revenues that have not been adequately
provided for in the accompanying condensed consolidated financial statements.


                                       9

<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)


      PROVISION FOR DOUBTFUL ACCOUNTS - The Company provides for accounts
receivable that could become uncollectible by establishing an allowance to
reduce the carrying value of such receivables to their estimated net realizable
value. The Hospitals estimate this allowance based on the aging of their
accounts receivable, historical collections experience for each type of payer
and other relevant factors. There are various factors that can impact the
collection trends, such as changes in the economy, which in turn have an impact
on unemployment rates and the number of uninsured and underinsured patients,
volume of patients through the emergency department, the increased burden of
co-payments to be made by patients with insurance and business practices related
to collection efforts. These factors continuously change and can have an impact
on collection trends and the estimation process.

      The Company's policy is to attempt to collect amounts due from patients,
including co-payments and deductibles due from patients with insurance, at the
time of service while complying with all federal and state laws and regulations,
including, but not limited to, the Emergency Medical Treatment and Labor Act
("EMTALA"). Generally, as required by EMTALA, patients may not be denied
emergency treatment due to inability to pay. Therefore, until the legally
required medical screening examination is complete and stabilization of the
patient has begun, services are performed prior to the verification of the
patient's insurance, if any. In non-emergency circumstances or for elective
procedures and services, it is the Hospitals' policy, when appropriate, to
verify insurance prior to a patient being treated.

      TRANSFERS OF FINANCIAL ASSETS - The Company sells substantially all of its
billed accounts receivable to a financing company (Note 2). The Company accounts
for its sale of accounts receivable in accordance with SFAS No. 140, "Accounting
for Transfers and Servicing of Financial Assets and Extinguishments of
Liabilities - A replacement of SFAS No. 125." A transfer of financial assets in
which the Company has surrendered control over those assets is accounted for as
a sale to the extent that consideration other than beneficial interests in the
transferred assets is received in exchange. Control over transferred assets is
surrendered only if all of the following conditions are met:

      1.    The transferred assets have been isolated from the transferor(i.e.,
            they are beyond the reach of the transferor and its creditors);
      2.    Each transferee has the unconditional right to pledge or exchange
            the transferred assets it received; and
      3.    The Company does not maintain effective control over the transferred
            assets either (a) through an agreement that entitles and obligates
            the transferor to repurchase or redeem the transferred assets before
            their maturity or (b) through the ability to unilaterally cause the
            holder to return specific assets, other than through a cleanup call.

      If a transfer of financial assets does not meet the criteria for a sale as
described above, the Company and transferee account for the transfer as a
secured borrowing with pledge of collateral, and accordingly the Company is
prevented from derecognizing the transferred financial assets. Where
derecognizing criteria are met and the transfer is accounted for as a sale, the
Company removes financial assets from the consolidated balance sheet and a net
loss is recognized in income at the time of sale. Effective October 9, 2007, the
Company repurchased all its sold accounts receivable (Note 11).

      CASH AND CASH EQUIVALENTS - The Company considers all highly liquid debt
investments purchased with a maturity of three months or less to be cash
equivalents. At times, cash balances held at financial institutions are in
excess of federal depository insurance limits. The Company has not experienced
any losses on cash and cash equivalents.

      Cash held in the Company's bank accounts as of September 30 and March 31,
2007, collected on behalf of the buyer of accounts receivable, is not included
in the Company's cash and cash equivalents.

      LETTERS OF CREDIT - At September 30, 2007, the Company has two outstanding
standby letters of credit totaling $1.4 million. These letters of credit were
issued by the Company's Lender and correspondingly reduce the Company's
borrowing availability under its line of credit with the Lender (Note 4).

      RESTRICTED CASH - As of September 30 and March 31, 2007, restricted cash
consists of amounts deposited in short term time deposits with a commercial bank
to collateralize the Company's obligations pursuant to certain agreements.


                                       10





<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)


      INVENTORIES OF SUPPLIES- Inventories consist of supplies valued at the
lower of average cost or market.

      PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less
accumulated depreciation and any impairment write-downs related to assets held
and used. Additions and improvements to property and equipment are capitalized
at cost. Expenditures for maintenance and repairs are charged to expense as
incurred. Capital leases are recorded at the beginning of the lease term as
property and equipment and a corresponding lease liability is recognized. The
value of the property and equipment under capital lease is recorded at the lower
of either the present value of the minimum lease payments or the fair value of
the asset. Such assets, including improvements, are amortized over the shorter
of either the lease term or their estimated useful life.

      The Company uses the straight-line method of depreciation for buildings
and improvements, and equipment over their estimated useful lives of 25 years
and 3 to 15 years, respectively.

      LONG-LIVED ASSETS - The Company evaluates its long-lived assets for
possible impairment whenever circumstances indicate that the carrying amount of
the asset, or related group of assets, may not be recoverable from estimated
future cash flows. However, there is an evaluation performed at least annually.
Fair value estimates are derived from independent appraisals, established market
values of comparable assets or internal calculations of estimated future net
cash flows. The estimates of future net cash flows are based on assumptions and
projections believed by the Company to be reasonable and supportable. These
assumptions take into account patient volumes, changes in payer mix, revenue,
and expense growth rates and changes in legislation and other payer payment
patterns. The Company believes there has been no impairment in the carrying
value of its property and equipment at September 30, 2007.

      DEBT ISSUANCE COSTS - These deferred charges related to credit agreement
fees (Note 4) and are amortized over the related lives of the agreements on an
effective interest method.

      MEDICAL CLAIMS INCURRED BUT NOT REPORTED - The Company was contracted with
CalOptima, which is a county sponsored entity that operates similarly to an HMO,
to provide health care services to indigent patients at a fixed amount per
enrolled member per month. Through April 2007, the Company received payments
from CalOptima based on a fixed fee multiplied by the number of enrolled members
at the Hospitals ("Capitation Fee"). The Company recognizes these Capitation
Fees as revenues on a monthly basis.

      In certain circumstances, members would receive health care services from
hospitals not owned by the Company. In these cases, the Company records
estimates of patient member claims incurred but not reported ("IBNR") for
services provided by other health care institutions. IBNR claims are estimated
using historical claims patterns, current enrollment trends, hospital
pre-authorizations, member utilization patterns, timeliness of claims
submissions, and other factors. There can, however, be no assurance that the
ultimate liability will not exceed estimates. Adjustments to the estimated IBNR
claims are recorded in the Company's results of operations in the periods when
such amounts are determinable. Per guidance under Statement of Financial
Accounting Standards ("SFAS") No. 5, the Company accrues for IBNR claims when it
is probable that expected future health care costs and maintenance costs under
an existing contract have been incurred and the amount can be reasonably
estimated. The Company records a charge related to these IBNR claims against its
net operating revenues. The Company's net revenues from CalOptima capitation,
net of third party claims and estimates of IBNR claims, for the three months
ended September 30, 2007 and 2006 were $0.14 million and $(0.67) million,
respectively, and $0.19 million and $1.13 million for the six months ended
September 30, 2007 and 2006, respectively. IBNR claims accruals at September 30
and March 31, 2007 were $2.8 million and $4.1 million, respectively. The
Company's direct cost of providing services to patient members is included in
the Company's normal operating expenses.


                                       11




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

      STOCK-BASED COMPENSATION - SFAS No. 123R, "Share Based Payment," requires
companies to record compensation cost for stock-based employee compensation
plans at fair value at the grant date. The Company has adopted SFAS No. 123R. On
August 6, 2007, the Company's Board of Directors approved the granting of
options with the right to purchase shares of the Company's common stock to
eligible employees (Note 7).

      FAIR VALUE OF FINANCIAL INSTRUMENTS - The Company's financial instruments
recorded in the consolidated balance sheets include cash and cash equivalents,
restricted cash, receivables, accounts payable, and other liabilities including
warrant liability and debt. The recorded carrying value of such financial
instruments approximates a reasonable estimate of their fair value.

      To finance the Acquisition, the Company entered into agreements that
contained warrants (Notes 4 and 5), which are required to be accounted for as
derivative liabilities in accordance with SFAS No. 133. A derivative is an
instrument whose value is derived from an underlying instrument or index such as
a future, forward, swap, or option contract, or other financial instrument with
similar characteristics, including certain derivative instruments embedded in
other contracts ("embedded derivatives") and for hedging activities. As a matter
of policy, the Company does not invest in separable financial derivatives or
engage in hedging transactions. However, the Company may engage in complex
transactions in the future that also may contain embedded derivatives.
Derivatives and embedded derivatives, if applicable, are measured at fair value
and marked to market through earnings.

      WARRANTS - In connection with its Acquisition of the Hospitals, the
Company entered into complex transactions that contain warrants requiring
accounting treatment in accordance with SFAS No. 133, SFAS No. 150 and EITF No.
00-19 (Notes 4 and 5).

      INCOME (LOSS) PER COMMON SHARE - Income (loss) per share is calculated in
accordance with SFAS No. 128, "Earnings per Share." Basic income (loss) per
share is based upon the weighted average number of common shares outstanding
(Note 8).

      INCOME TAXES - The Company accounts for income taxes in accordance with
SFAS No. 109, "Accounting for Income Taxes," which requires the liability
approach for the effect of income taxes. Under SFAS No. 109, deferred income tax
assets and liabilities are determined based on the differences between the book
and tax basis of assets and liabilities and are measured using the currently
enacted tax rates and laws. The Company assesses the realization of deferred tax
assets to determine whether an income tax valuation allowance is required. The
Company has recorded a 100% valuation allowance on its deferred tax assets.

      On July 13, 2006, the FASB issued FIN 48, "Accounting for Uncertainty in
Income Taxes - an interpretation of FASB Statement No. 109," which clarifies the
accounting and disclosure for uncertain tax positions. This interpretation is
effective for fiscal years beginning after December 15, 2006 and the Company has
implemented this interpretation as of April 1, 2007. FIN 48 prescribes a
recognition threshold and measurement attribute for recognition and measurement
of a tax position taken or expected to be taken in a tax return. FIN 48 also
provides guidance on de-recognition, classification, interest and penalties,
accounting in interim periods, disclosure and transition.

      Under FIN 48, evaluation of a tax position is a two-step process. The
first step is to determine whether it is more-likely-than-not that a tax
position will be sustained upon examination, including the resolution of any
related appeals or litigation based on the technical merits of that position.
The second step is to measure a tax position that meets the more-likely-than-not
threshold to determine the amount of benefit to be recognized in the financial
statements. A tax position is measured at the largest amount of benefit that is
greater than 50 percent likely of being realized upon ultimate settlement. Tax
positions that previously failed to meet the more-likely-than-not recognition
threshold should be recognized in the first subsequent period in which the
threshold is met. Previously recognized tax positions that no longer meet the
more-likely-than-not criteria should be de-recognized in the first subsequent
financial reporting period in which the threshold is no longer met.


                                       12




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)


      The adoption of FIN 48 at April 1, 2007 did not have a material effect on
the Company's financial position.

      The Company and its subsidiaries file income tax returns in the U.S.
federal jurisdiction and California. The Company is no longer subject to U.S.
federal and state income tax examinations by tax authorities for years before
December 31, 2003 and December 31, 2002, respectively. Certain tax attributes
carried over from prior years continue to be subject to adjustment by taxing
authorities.

      SEGMENT REPORTING - The Company operates in one line of business, the
provision of health care services through the operation of general hospitals and
related health care facilities. The Company's Hospitals generated substantially
all of its net operating revenues during the periods since the Acquisition.

      The Company's four general Hospitals and related health care facilities
operate in one geographic region in Orange County, California. The region's
economic characteristics, the nature of the Hospitals' operations, the
regulatory environment in which they operate, and the manner in which they are
managed are all similar. This region is an operating segment, as defined by SFAS
No. 131. In addition, the Company's general Hospitals and related health care
facilities share certain resources and benefit from many common clinical and
management practices. Accordingly, the Company aggregates the facilities into a
single reportable operating segment.

      RECENTLY ENACTED ACCOUNTING STANDARDS - In March 2006, the FASB issued
SFAS No. 156, "Accounting for Servicing of Financial Assets - an amendment of
FASB Statement No. 140," with respect to the accounting for separately
recognized servicing assets and servicing liabilities. SFAS 156 permits the
choice of either the amortization method or the fair value measurement method,
with changes in fair value recorded in the consolidated statement of operations,
for the subsequent measurement for each class of separately recognized servicing
assets and servicing liabilities. The statement is effective for years beginning
after September 15, 2006, with earlier adoption permitted. The adoption of this
statement did not have a material impact on the Company's consolidated financial
position and results of operations.

      In September 2006, the FASB issued SFAS No. 157, "Fair Value
Measurements." This Statement establishes a single authoritative definition of
fair value, sets out a framework for measuring fair value, and requires
additional disclosures about fair value measurements. FASB 157 applies only to
fair value measurements that are already required or permitted by other
accounting standards. The statement is effective for financial statements for
fiscal years beginning after November 15, 2007, with earlier adoption permitted.
The Company is evaluating the impact, if any, that the adoption of this
statement will have on its consolidated results of operations and financial
position.

      In February 2007, the FASB issued SFAS No. 159, "The Fair Value Option for
Financial Assets and Financial Liabilities-Including an amendment of FASB
Statement No. 115." SFAS 159 permits entities to choose to measure many
financial instruments and certain other items at fair value. Most of the
provisions of SFAS 159 apply only to entities that elect the fair value option;
however, the amendment to FASB Statement No. 115, "Accounting for Certain
Investments in Debt and Equity Securities," applies to all entities with
available for sale and trading securities. The statement is effective for
financial statements for fiscal years beginning after November 15, 2007. The
Company is evaluating the impact, if any, that the adoption of this statement
will have on its consolidated results of operations and financial position.


                                       13





<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  SEPTEMBER 30, 2007
                                   (UNAUDITED)


NOTE 2 - ACCOUNTS PURCHASE AGREEMENT

      In March 2005, the Company entered into an Accounts Purchase Agreement
(the "APA") for a minimum of two years with Medical Provider Financial
Corporation I, an unrelated party (the "Buyer"). The Buyer is an affiliate of
the Lender (Note 4). The APA provides for the sale of 100% of the Company's
eligible accounts receivable, as defined, without recourse. The APA provides for
the Company to provide billing and collection services, maintain the individual
patient accounts, and resolve any disputes that arise between the Company and
the patient or other third party payer for no additional consideration.

      The accounts receivable are sold weekly based on separate bills of sale
for each Hospital. The purchase price is comprised of two components, the
Advance Rate Amount and the Deferred Purchase Price Receivable amount, as
defined. The Advance Rate Amount is based on the Buyer's appraisal of accounts
receivable accounts. The Buyer's appraisal is developed internally by the Buyer
and does not necessarily reflect the net realizable value or the fair value of
the accounts receivable sold. At the time of sale, the Buyer advances 95% of the
Buyer's appraised value (the "95% Advance) on eligible accounts to the Company
and holds the remaining 5% as part of the security reserve funds on sold
accounts (the "Security Reserve Funds"), which is non-interest bearing. Except
in the case of a continuing default, the Security Reserve Funds can not exceed
15% (the "15% Cap") of the aggregate Advance Rate Amount of the open purchases.
The Company is charged a "purchase discount" (the "Transaction Fee") of 1.35%
per month of the Advance Rate Amount of each tranche of accounts receivable
accounts purchased until closed based on application of cash collections up to
the Advance Rate Amount for that tranche, at which time the Buyer deducts the
Transaction Fee from the Security Reserve Funds. The Company holds cash
collected in its lockbox in a fiduciary role for the Buyer and records the cash
as part of Security Reserve Funds. Collections are applied by the Buyer on a
dollar value basis, not by specific identification, to the respective Hospital's
most aged open purchase until the tranche is closed. The APA further provides
that if the amount collected (as to each account purchased within 180 days of
the billing date on any account, including substitute assets, purchased by
Buyer) is less than the amount of its Adjusted Value, as defined, then such
seller shall remit to Buyer the amount of such difference between the Adjusted
Value of the account and the amount actually collected on such account by Buyer
as the repurchase price for such account. If the Seller fails to repurchase such
accounts, the Buyer shall deduct from the Advance Rate Amount and Deferred
Purchase Price otherwise payable for all accounts with respect to any purchase,
an amount equal to the Adjusted Value of such uncollected account less the
deferred portion of the purchase price thereof, thereby closing the tranche.
These provisions have not been applied in the contract to date due to the timely
closure of tranches.

      Collections in excess of the Advance Rate Amount are credited by the Buyer
to Security Reserve Funds and ultimately released to the Company to pay down the
Deferred Purchase Price Receivable. The Deferred Purchase Price Receivable
approximates fair value and represents amounts the Company expects to collect,
based on regulations, contracts, and historical collection experience, in excess
of the Advance Rate Amount. In determining the fair value of the Deferred
Purchase Price Receivable recorded upon sales of accounts receivable accounts
under the APA, the key assumption used is the application of a short-term
discount rate. If the discount rate applied increased by 10%, the adverse effect
on the Deferred Purchase Price Receivable and related loss on sale of accounts
receivable would be insignificant. The Deferred Purchase Price Receivable is
unsecured.

      From inception of the APA through September 30, 2007, the Buyer has
advanced $629.3 million to the Company through the APA. In addition, the Company
has received $54.9 million in reserve releases from inception through September
30, 2007. Payments posted on sold receivables from inception have approximated
$690.6 million. Advances net of payment and adjustment activity, cumulatively
through September 30 and March 31, 2007 were ($7.7) million and $7.0 million,
respectively. Transaction Fees incurred for the same periods (from inception)
were $11.5 million and $9.3 million, respectively.


                                       14





<PAGE>
                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

      The following table reconciles accounts receivable at September 30 and
March 31, 2007, as reported, to the pro forma accounts receivable, as if the
Company had deferred recognition of the sales (non GAAP) (in thousands).

<TABLE>
                                                      September 30, 2007                     March 31, 2007
                                              ----------------------------------    ----------------------------------
                                                As reported         Pro Forma         As reported         Pro Forma
                                              ---------------    ---------------    ---------------    ---------------
<S>                                           <C>                <C>                <C>                <C>
Accounts receivable
        Governmental                          $         9,497    $        25,447    $         7,958    $        25,621
        Non-governmental                               13,791             48,977             13,767             51,229
                                              ---------------    ---------------    ---------------    ---------------
                                                       23,288             74,424             21,725             76,850
Less allowance for doubtful accounts                   (1,822)           (18,224)            (2,355)           (16,267)
                                              ---------------    ---------------    ---------------    ---------------
        Net patient accounts receivable                21,466             56,200             19,370             60,583
                                              ---------------    ---------------    ---------------    ---------------
Security reserve funds                                 18,332                  -              7,990                  -
Deferred purchase price receivable                     12,543                  -             16,975                  -
                                              ---------------    ---------------    ---------------    ---------------
        Receivable from Buyer of accounts              30,875                  -             24,965                  -
                                              ---------------    ---------------    ---------------    ---------------
Advance rate amount, net                                    -              7,662                  -             (6,957)
Transaction Fees deducted from Security
        Reserve Funds                                       -            (11,521)                 -             (9,291)
                                              ---------------    ---------------    ---------------    ---------------
                                              $        52,341    $        52,341    $        44,335    $        44,335
                                              ===============    ===============    ===============    ===============
</TABLE>

      Any other term of the APA notwithstanding, the parties agreed as follows:
(a) all accounts derived from any government program payer including, without
limitation, the Medicare, Medi-Cal, or CHAMPUS programs, shall be handled as set
forth in a Deposit Account Security Agreement entered into by the parties, which
provides for the segregation and control of governmental payments by the
Company, (b) the parties agreed to take such further actions and execute such
further agreements as are reasonably necessary to effectuate the purpose of the
APA and to comply with the laws, rules, and regulations of the Medicare and
other government programs regarding the reassignment of claims and payment of
claims to parties other than the provider ("Reassignment Rules"), and (c) until
such time as accounts are delivered by the Company to the Buyer controlled
lockbox, the Company shall at all times have sole dominion and control over all
payments due from any government program payer. The Company believes that the
foregoing method of segregating and controlling payments received from
governmental program payers complies with all applicable Reassignment Rules. As
of September 30, 2007 as shown above as the difference between the accounts
receivable - governmental as reported versus proforma amounts, the Company had
$15,950 thousand in governmental accounts receivable that had been reported as
sold which were subject to the foregoing limitation.

      The Company records estimated Transaction Fees and estimated servicing
liability related to the sold accounts receivable at the time of sale. The
estimated servicing liability is recorded at cost which approximates fair value
of providing such services. The loss on sale of accounts receivable is comprised
of the following (in thousands).

<TABLE>
                                                    For the three months ended                 For the six months ended
                                            ----------------------------------------    ----------------------------------------
                                            September 30, 2007    September 30, 2006    September 30, 2007    September 30, 2006
                                            ------------------    ------------------    ------------------    ------------------
<S>                                         <C>                   <C>                   <C>                   <C>
Transaction Fees deducted from
   Security Reserve Funds -
   closed purchases                         $            1,145    $              900    $            2,230    $            2,115
Change in accrued Transaction Fees -
   open purchases                                          (72)                  285                  (104)                  234
                                            ------------------    ------------------    ------------------    ------------------
   Total Transaction Fees incurred                       1,073                 1,185                 2,126                 2,349
                                            ------------------    ------------------    ------------------    ------------------
Servicing expense for sold accounts
   receivable - closed purchases                         1,487                 1,291                 3,021                 2,557
Change in accrued servicing expense
   for sold accounts receivable -
   open purchases                                         (149)                  154                  (150)                   63
                                            ------------------    ------------------    ------------------    ------------------
   Total servicing expense incurred                      1,338                 1,445                 2,871                 2,620
                                            ------------------    ------------------    ------------------    ------------------
Loss on sale of accounts receivable
   for the period                           $            2,411    $            2,630    $            4,997    $            4,969
                                            ==================    ==================    ==================    ==================
</TABLE>
                                       15
<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)


      The related accrued Transaction Fee and accrued servicing liabilities
included in other current liabilities on the accompanying condensed consolidated
balance sheets are as follows (in thousands).

                                            September 30,        March 31,
                                                2007               2007
                                           ---------------    ---------------

Transaction fee liability                  $         1,129    $         1,233
Accrued servicing liability                $           640    $           789

      The accrued servicing liability recorded at September 30 and March 31,
2007, approximates fair value in accordance with SFAS No. 140.

      The Company reacquired all previously sold receivables in October 2007
(Note 11).

NOTE 3 - PROPERTY AND EQUIPMENT

      Property and equipment consists of the following (in thousands).

                                            September 30,        March 31,
                                                2007               2007
                                           ---------------    ---------------

Buildings                                  $        33,697    $        33,697
Land and improvements                               13,523             13,523
Equipment                                           10,066              9,694
Assets under capital leases                          6,505              6,505
                                           ---------------    ---------------
                                                    63,791             63,419
Less accumulated depreciation                       (6,840)            (5,247)
                                           ---------------    ---------------
        Property and equipment, net        $        56,951    $        58,172
                                           ===============    ===============

      Essentially all land and buildings are owned by PCHI (Notes 9 and 10).

      The Hospitals are located in an area near active and substantial
earthquake faults. The Hospitals carry earthquake insurance with a policy limit
of $50.0 million. A significant earthquake could result in material damage and
temporary or permanent cessation of operations at one or more of the Hospitals.

      In addition, the State of California has imposed new hospital seismic
safety requirements. Under these new requirements, the Hospitals must meet
stringent seismic safety criteria in the future and must complete one set of
seismic upgrades to each facility by January 1, 2013. This first set of upgrades
is expected to require the Company to incur substantial seismic retrofit
expenses. In addition, there could be other remediation costs pursuant to this
seismic retrofit.

      There are additional requirements that must be complied with by 2030. The
costs of meeting these requirements have not yet been determined. Compliance
with seismic ordinances will be a costly venture and could have a material
adverse effect on the Company's cash flow.


                                       16





<PAGE>

                       INTEGRATED HEALTHCARE HOLDINGS, INC.
               NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)


NOTE 4 - DEBT

      The Company's debt payable to affiliates of Medical Capital Corporation,
namely Medical Provider Financial Corporation II and Medical Provider Financial
Corporation III (the "Lender(s)") consists of the following as of September 30
and March 31, 2007 (in thousands).

      Secured note                                              $   10,700
      Less derivative - warrant liability, current                 (10,700)
      Secured acquisition loan                                      45,000
      Secured line of credit, outstanding borrowings                27,341
                                                                ----------
        Total - all current                                     $   72,341
                                                                ==========

      SECURED ACQUISITION LOAN AND NON-REVOLVING LINE OF CREDIT - Effective
March 3, 2005, the Company entered into a credit agreement (the "Credit
Agreement") with the Lenders, whereby the Company obtained initial financing
with annual interest at the rate of 14% (as amended January 1, 2006) in the
amount of $80.0 million, consisting of a $30.0 million non-revolving Line of
Credit and a $50.0 million Acquisition Loan (less $5.0 million repayment on
December 12, 2005) in the form of a real estate loan (collectively, the
"Obligations"). The Company used the proceeds from the $50.0 million Acquisition
Loan and $3.0 million from the Line of Credit to complete the Acquisition (Note
1). The Line of Credit was used for the purpose of providing (a) working capital
financing for the Company and its subsidiaries, (b) funds for other general
corporate purposes of the Company and its subsidiaries, and (c) other permitted
purposes, as defined.

      Interest payments are due on the Obligations on the first business day of
each calendar month while any Obligation is outstanding. The Obligations matured
on March 2, 2007. Under the Credit Agreement, all future capital contributions
to the Company by Orange County Physicians Investment Network, LLC ("OC-PIN")
shall be used by the Company as mandatory prepayments of the Line of Credit.

      The Acquisition Loan and Line of Credit are secured by a lien on
substantially all of the assets of the Company and its subsidiaries, including,
without limitation, a pledge of the capital stock by the Company in its wholly
owned Hospitals. In addition, (i) PCHI has agreed to guaranty the payment and
performance of the Obligations, (ii) West Coast Holdings, LLC ("West Coast") and
Ganesha Realty, LLC ("Ganesha"), (the members of PCHI), have each agreed to
pledge their membership interests in PCHI as security for repayment of the
Obligations, (iii) the members of West Coast have agreed to pledge their
membership interests in PCHI as security for repayment of the Obligations, and
(iv) OC-PIN (Note 6) has agreed to guaranty the payment and performance of all
the Obligations.

      As of September 30, 2007, the Company had no remaining availability under
its $30.0 million Line of Credit as the maturity date has passed.

      SECURED SHORT TERM NOTE - On December 12, 2005, the Company entered into a
credit agreement (the "December Credit Agreement") with the Lender. Under the
December Credit Agreement, the Lender loaned $10.7 million to the Company (the
"December Note").

      Interest on the December Note is payable monthly at the rate of 12% per
annum.

      The December Note is secured by substantially all of the Company's assets.
In addition, the Company issued a common stock warrant (the "December Note
Warrant") to the Lender as collateral under the December Note. The December Note
Warrant is exercisable by the Lender only in the event that a default has
occurred and is continuing on the December Note. The Company has classified the
December Note as current warrant liability in the accompanying condensed
consolidated balance sheets as of September 30 and March 31, 2007 (Note 5).

      The December Note originally matured on December 12, 2006 but was extended
through March 2, 2007 pursuant to an agreement dated December 22, 2006.
Additionally, the parties to the Credit Agreement, namely the Company, PCHI,
West Coast, OC-PIN, Ganesha, and the Lenders executed an Agreement (the
"December Forbearance Agreement") relating to the Credit Agreement and the
December Note issued in connection with the original Credit Agreement. The
December Forbearance Agreement extended the maturity date of all the debt
through March 2, 2007.


                                       17




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

      DEFAULT AND FORBEARANCE - On June 13, 2007, the Company received a notice
of default on its debt from the Lender(s). On June 18, 2007, the Company entered
into a Forbearance Agreement" with the Lender(s). This agreement provided, among
other provisions, that the Lender(s) will forgo exercising any of its rights and
remedies under the various credit agreements for ninety days through September
30, 2007, including filing a judicial foreclosure action and charging default
interest on the $80.0 million credit agreement. Effective October 9, 2007, the
Company entered into new loan agreements with the Lenders effectively
refinancing all its matured debt (Note 11).

NOTE 5 - COMMON STOCK WARRANTS

      DECEMBER NOTE WARRANT - In accordance with SFAS No. 150, the Company has
included the December Note value of $10.7 million in warrant liabilities,
current, in the accompanying condensed consolidated balance sheets as of
September 30 and March 31, 2007 and recomputed the fair value in accordance with
SFAS No. 133 at each reporting date. Under the terms of the December Credit
Agreement, any proceeds from the sale of stock received under the December Note
Warrant that are in excess of the December Note and related issuance costs are
to be paid to the Company as paid in capital. Accordingly, the fair value of the
December Note Warrant would contractually continue to be $10.7 million (plus any
issuance and exercise costs, which are considered immaterial).

      At September 30 and March 31, 2007, the estimated potential number of
shares was calculated using the market price and $10.7 million liability of the
Company. The estimated number of shares was 53.5 million and 33.4 million,
respectively. The maximum number of shares issuable in the event of default in
accordance with the December Note Warrant agreement however, is the greatest of:
(1) 26.1 million Shares of Common Stock, (2) Shares representing 31.09% of all
Common Stock and Common Stock Equivalents of the Company, or 61.9 million at
September 30 and March 31, 2007, respectively, and (3) the fair market value of
Shares of Common Stock equal to the amount of the $10.7 million loan not repaid
at maturity or default of such Loan, plus any accrued and unpaid interest
thereon, Lender's fees, costs and expenses, and attorneys' fees. Any amounts
received by the lender from the sale of stock they received when they exercise
the warrants in excess of that required to retire the $10.7 million debt would
be paid to the Company as additional paid in capital.

      RESTRUCTURING WARRANTS - The Company entered into a Rescission,
Restructuring and Assignment Agreement with Dr. Kali Chaudhuri and Mr. William
Thomas on January 27, 2005 (the "Restructuring Agreement"). Pursuant to the
Restructuring Agreement, the Company issued warrants to purchase up to 74.7
million shares of the Company's common stock (the "Restructuring Warrants") to
Dr. Chaudhuri and Mr. Thomas (not to exceed 24.9% of the Company's fully diluted
capital stock at the time of exercise). In addition, the Company amended the
Real Estate Option to provide for Dr. Chaudhuri's purchase of a 49% interest in
PCHI for $2.45 million.

      The Restructuring Warrants were exercisable beginning January 27, 2007 and
expire on July 27, 2008. The exercise price for the first 43 million shares
purchased under the Restructuring Warrants is $0.003125 per share, and the
exercise or purchase price for the remaining 31.7 million shares is $0.078 per
share if exercised between January 27, 2007 and July 26, 2007, $0.11 per share
if exercised between July 27, 2007 and January 26, 2008, and $0.15 per share
thereafter. In accordance with SFAS No. 133 and EITF 00-19, these warrants are
accounted for as liabilities and are revalued at each reporting date, and the
changes in fair value are recorded as change in fair value of derivative on the
consolidated statement of operations.

      During February 2007, Dr. Chaudhuri and Mr. Thomas submitted an exercise
under these warrants to the Company. At March 31, 2007 the Company recorded the
issuance of 28.7 million net shares under this exercise following resolution of
certain legal issues relating thereto. The issuance of these shares resulted in
an addition to paid in capital and to common stock totaling $9,199 thousand.
These shares were issued to Dr. Chaudhuri and Mr. Thomas on July 2, 2007. The
shares pursuant to this exercise were recorded as issued and outstanding at
March 31, 2007. Additionally, the remaining liability was revalued at March 31,
2007 in the amount of $4.2 million relating to potential shares (20.8 million
shares) which could be issued, if the December Note warrant was to become
issuable, which occurred on June 13, 2007 upon receipt of a notice of default
from the Lender.

      On July 2, 2007, the Company accepted, due to the default and subsequent
vesting of the December Note Warrant, an additional exercise under the
anti-dilution provisions the Restructuring Warrant Agreement by Dr. Chaudhuri
and Mr. Thomas. The exercise resulted in additional shares issuable of 20.8
million shares for consideration of $576 thousand in cash. The effect of this
exercise resulted in additional warrant expense for the year ended March 31,
2007 of $693 thousand, which was accrued based on the transaction as of March
31, 2007.


                                       18




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)


      The Company recorded a change in the fair value of derivative of (in
thousands) $0 and a gain of $779 for the three months ended September 30, 2007
and 2006, respectively, and (in thousands) $0 and a gain of $5,145 for the six
months ended September 30, 2007 and 2006, respectively. The related warrant
liability of $4.2 million (as of March 31, 2007) was reclassified to additional
paid in capital when the 20.8 million shares were issued to Dr. Chaudhuri and
Mr. Thomas in July 2007.

      As a result of the Company's refinancing (Note 11), the remaining 24.9
million warrants held by Dr. Chaudhuri and Mr. Thomas became exercisable on the
October 9, 2007 effective date of the refinancing and will result in an
estimated $1.5 million in warrant expense at such date.

NOTE 6 - COMMON STOCK

      STOCK PURCHASE AGREEMENT - On January 28, 2005, the Company entered into a
Stock Purchase Agreement (the "Stock Purchase Agreement") with OC-PIN a company
founded by Dr. Anil V. Shah, a board member, and owned by a number of physicians
practicing at the acquired Hospitals. This agreement was subsequently amended to
include the following:

      Under the First Amendment and the related Escrow Agreement, OC-PIN
deposited a total of $12.5 million into the escrow account. However, following
receipt of such funds, a disagreement arose between OC-PIN and the third party
which provided $11.0 million of the $12.5 million deposited into the escrow
account. In order to resolve this matter and to avoid potential litigation
involving the Company, the Company agreed to return $11.0 million of these funds
and provide OC-PIN with a limited opportunity to provide alternative financing.
Therefore, effective October 31, 2005, the Company entered into a Second
Amendment to the Stock Purchase Agreement (the "Second Amendment"), pursuant to
which the Company and OC-PIN issued escrow instructions to release escrowed
funds as of November 2, 2005, terminate the Escrow Agreement and distribute the
assets in the escrow account as follows:

      1.    $1.5 million of the escrowed cash, plus a pro rata portion of the
            accrued interest, was delivered to the Company for payment of stock.

      2.    $11.0 million of the escrowed cash, plus a pro rata portion of the
            accrued interest was delivered to OC-PIN.

      3.    5.8 million of the escrowed shares of the Company's common stock
            were delivered to OC-PIN.

      4.    40.6 million of the escrowed shares of the Company's common stock
            were delivered to the Company.

      5.    OC-PIN transferred $2.8 million from another account to the Company
            for which OC-PIN received 10.8 million of the escrowed shares.

      6.    The Company agreed to issue to OC-PIN 5.4 million shares of its
            common stock multiplied by the percentage of OC-PIN's payment
            required to be made under the Stock Purchase Agreement, as amended,
            which had been made to date.

      7.    The Company granted OC-PIN the right to purchase up to $6.7 million
            of common stock within 30 calendar days following the cure of the
            Company's default relating to the Credit Agreement at a price of
            $0.2586728 per share or a maximum of 25.9 million shares of its
            common stock, plus interest on the purchase price at 14% per annum
            from September 12, 2005 through the date of closing on the funds
            from OC-PIN. Upon one or more closings on funds received under this
            section of the Second Amendment, the Company agreed to issue an
            additional portion of the 5.4 million shares mentioned in item (6)
            above. On September 12, 2006, the Company issued 3.2 million of
            these shares to OC-PIN in full resolution of the Stock Purchase
            Agreement.

      The Company's debt covenants restrict the ability to pay dividends.


                                       19




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

NOTE 7 - STOCK OPTION PLAN

      The Company's 2006 Stock Incentive Plan (the "Plan"), which is
shareholder-approved, permits the grant of share options to its employees and
board members for up to 20 million shares of common stock. The Company believes
that such awards better align the interests of its employees with those of its
shareholders. In accordance with the Plan, incentive stock options,
non-qualified stock options, and performance based compensation awards may not
be granted at less than 100 percent of the estimated fair market value of the
common stock on the date of grant. Incentive stock options granted to a person
owning more than 10 percent of the voting power of all classes of stock of the
Company may not be issued at less than 110 percent of the fair market value of
the stock on the date of grant. Option awards generally vest based on 3 years of
continuous service (1/3 of the shares vest on the twelve month anniversary of
the grant date, and an additional 1/12 of the shares vest on each subsequent
fiscal quarter-end of the Company following such twelve month anniversary).
Certain option awards provide for accelerated vesting if there is a change of
control, as defined. The option awards have 7-year contractual terms.

      On August 6, 2007, the Board of Directors approved the initial granting of
options with the right to purchase an aggregate of 4,795 thousand shares of the
Company's common stock to eligible employees pursuant to the Plan. The grant
price approved on that date is $0.26 per share. For options granted to employees
who have been employed by the Company since its March 8, 2005 inception, vesting
retroactively commenced on March 8, 2005. Of the total options granted, 3,500
thousand are subject to this retroactive vesting. Vesting of the remaining 1,295
thousand granted options commenced on the August 6, 2007 grant date.

      When the measurement date is certain, the fair value of each option grant
is estimated on the date of grant using the Black-Scholes valuation model and
the assumptions noted in the table below. Since there is limited historical data
with respect to both pre-vesting forfeiture and post-vesting termination, the
expected life of the options was determined utilizing the simplified method
described in the SEC's Staff Accounting Bulletin 107 ("SAB 107"). SAB 107
provides guidance whereby the expected term is calculated by taking the sum of
the vesting term plus the original contractual term and dividing that quantity
by two. The expected volatility is based on an analysis, performed by an
independent valuation firm, of the Company's stock and the stock of the
following publicly traded companies that own hospitals.

                                 Amsurg Inc. (AMSG)
                                 Community Health Systems (CYH)
                                 HCA Healthcare Company (HCA)
                                 Health Management Associates Inc. (HMA)
                                 Lifepoint Hospitals Inc. (LPNT)
                                 Medcath Corp. (MDTH)
                                 Tenet Healthcare Corp. (THC)
                                 Triad Hospitals Inc. (TRI)
                                 Universal Health Services Inc. Class B (USH)

      The risk-free interest rate is based on the average yield on U.S. Treasury
zero-coupon issues with remaining terms equal to the expected terms of the
options. The dividend yield reflects that the Company has not paid any cash
dividends since inception and does not anticipate paying cash dividends in the
foreseeable future.

Expected dividend yield                                     0.0%

Risk-free interest rate                                     4.5%

Expected volatility                                32.3% - 36.0%

Expected term (in years)                               3.6 - 4.4


                                       20




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

      In accordance with SFAS No. 123R, the Company recorded $57.8 thousand of
compensation expense relative to stock options during the three months ended
September 30, 2007, the first period in which options were granted. A summary of
stock option activity for the three months ended September 30, 2007 is presented
as follows (there was no prior stock option activity).

<TABLE>
                                                                          Weighted-
                                                           Weighted-       average
                                                            average       remaining      Aggregate
                                                           exercise      contractual     intrinsic
                                             Shares          price          term           value
                                         --------------   -----------   -------------   -----------
<S>                                               <C>     <C>                     <C>   <C>
Outstanding, June 30, 2007                            -             -
   Granted                                        4,795   $      0.26
   Exercised                                          -   $         -
   Forfeited or expired                               -   $         -
                                         --------------
Outstanding, September 30, 2007                   4,795   $      0.26             6.8   $         -
                                         ==============   ===========   =============   ===========
Exercisable at September 30, 2007                 2,917   $      0.26             6.8   $         -
                                         ==============   ===========   =============   ===========
</TABLE>

      The weighted average grant date fair value of employee stock options
granted during the three months ended September 30, 2007 was $0.16. No options
were exercised during the three months ended September 30, 2007.

      A summary of the Company's nonvested shares as of September 30, 2007, and
changes during the three months ended September 30, 2007, is presented below:

                                                           Weighted-
                                                            average
                                                           grant date
                                             Shares        fair value
                                         --------------   ------------

Nonvested at June 30, 2007                            -   $          -
Granted                                           1,878   $       0.16
Vested                                                -   $          -
Forfeited                                             -   $          -
                                         --------------
Nonvested at September 30, 2007                   1,878   $       0.16
                                         ==============

      As of September 30, 2007, there was $50.6 thousand of total unrecognized
compensation expense related to nonvested share-based compensation arrangements
granted under the Plan. That cost is expected to be recognized over a
weighted-average period of 2.2 years.

NOTE 8 - INCOME (LOSS) PER SHARE

      Income (loss) per share has been calculated under SFAS No. 128, "Earnings
per Share." SFAS 128 requires companies to compute income (loss) per share under
two different methods, basic and diluted. Basic income (loss) per share is
calculated by dividing the net income (loss) by the weighted average shares of
common stock outstanding during the period. Diluted income (loss) per share is
calculated by dividing the net income (loss) by the weighted average shares of
common stock outstanding during the period and dilutive potential shares of
common stock. Dilutive potential shares of common stock, as determined under the
treasury stock method, consist of shares of common stock issuable upon exercise
of stock warrants or options, net of shares of common stock assumed to be
repurchased by the Company from the exercise proceeds.

      Since the Company incurred losses for the six months ended September 30,
2007, anti dilutive potential shares of common stock, consisting of 61.9 million
shares, issuable under warrants, have been excluded from the calculations of
diluted loss per share for the period.

      Since the Company incurred losses for the three and six months ended
September 30, 2006, antidilutive potential shares of common stock consisting of
40.0 million issuable under warrants have been excluded from the calculations of
diluted loss per share for the period.

                                       21




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

      Income per share for the three months ended September 30, 2007 was
computed as follows (in thousands except for per share amounts). Stock options
were not included in the diluted calculation since they were not in-the-money
during the three months ended September 30, 2007.

Numerator:
        Net income                                     $          1,126
                                                       ================

Denominator:
        Weighted average common shares                          136,870
        Warrants                                                 53,500
                                                       ----------------

        Denominator for diluted calculation                     190,370
                                                       ================


Income per share - basic                               $           0.01
Income per share - diluted                             $           0.01

NOTE 9 - RELATED PARTY TRANSACTIONS

      PCHI - The Company leases substantially all of the real property of the
acquired Hospitals from PCHI. PCHI is owned by two LLC's, namely West Coast and
Ganesha; which are owned and co-managed by Dr. Shah, Dr. Chaudhuri, and Mr.
Thomas. Dr. Shah is also the co-manager and an investor in OC-PIN, which is the
largest shareholder of the Company. As the result of the partial exercise of the
Restructuring Warrants, Dr. Chaudhuri and Mr. Thomas are constructively the
holders of 49.5 million and 28.7 million shares of the outstanding stock of the
Company as of September 30 and March 31, 2007, respectively. They are also the
owners of the Restructuring Warrants to purchase up to 24.9 million shares of
future stock in the Company, issuable as of October 9, 2007 due to an anti
dilution feature of the warrant (Note 11). As described in Note 1, PCHI is a
variable interest entity and, accordingly, the Company has consolidated the
financial statements of PCHI in the accompanying condensed consolidated
financial statements.

      During the three and six months ended September 30, 2007, the Company paid
$1.1 million and $2.1 million, respectively, to a supplier that is also a
shareholder of the Company. For the same periods in 2006, the Company paid $0.6
million and $1.2 million, respectively, to the supplier.

NOTE 10 - COMMITMENTS AND CONTINGENCIES

      OPERATING LEASES - Concurrent with the closing of the Acquisition as of
March 8, 2005, the Company entered into a sale leaseback type agreement with a
related party entity, PCHI. The Company leases substantially all of the real
estate of the acquired Hospitals and medical office buildings from PCHI. The
term of the lease for the Hospitals is approximately 25 years, commencing March
8, 2005 and terminating on February 28, 2030. The Company has the option to
extend the term of this triple net lease for an additional term of 25 years.
Effective October 1, 2007, this lease was amended and restated (Note 11). This
lease commitment with PCHI is eliminated in consolidation (Note 9).

      CAPITAL LEASES - In connection with the Hospital Acquisition, the Company
also assumed the leases for the Chapman facility, which include buildings, land,
and other equipment with terms that were extended concurrently with the
assignment of the leases to December 31, 2023.


                                       22




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

      INSURANCE - The Company accrues for estimated general and professional
liability claims, to the extent not covered by insurance, when they are probable
and reasonably estimable. The Company has purchased as primary coverage a
claims-made form insurance policy for general and professional liability risks.
Estimated losses within general and professional liability retentions from
claims incurred and reported, along with IBNR claims, are accrued based upon
projections determined by an independent actuary and are discounted to their net
present value using a weighted average risk-free discount rate of 5%. To the
extent that subsequent claims information varies from estimates, the liability
is adjusted in the period such information becomes available. As of September 30
and March 31, 2007, the Company had accrued $7.2 million and $4.9 million,
respectively, which is comprised of $1.6 million and $1.4 million, respectively,
in incurred and reported claims, along with $5.6 million and $3.5 million,
respectively, in estimated IBNR.

      The Company has also purchased occurrence coverage insurance to fund its
obligations under its workers' compensation program. The Company has a
"guaranteed cost" policy, under which the carrier pays all workers' compensation
claims, with no deductible or reimbursement required of the Company. The Company
accrues for estimated workers' compensation claims, to the extent not covered by
insurance, when they are probable and reasonably estimable. The ultimate costs
related to this program include expenses for deductible amounts associated with
claims incurred and reported in addition to an accrual for the estimated
expenses incurred in connection with IBNR claims. Claims are accrued based upon
projections determined by an independent actuary and are discounted to their net
present value using a weighted average risk-free discount rate of 5%. To the
extent that subsequent claims information varies from estimates, the liability
is adjusted in the period such information becomes available. As of September 30
and March 31, 2007, the Company had accrued $1.0 million and $1.0 million,
respectively, comprised of $0.3 million and $0.2 million, respectively, in
incurred and reported claims, along with $0.7 million and $0.8 million,
respectively, in estimated IBNR.

      Effective May 1, 2007, the Company initiated a self-insured health
benefits plan for its employees. As a result, the Company has established and
maintains an accrual for IBNR claims arising from self-insured health benefits
provided to employees. The Company's IBNR accrual at September 30, 2007 was
based upon projections determined by an independent actuary. The Company
determines the adequacy of this accrual by evaluating its limited historical
experience and trends related to both health insurance claims and payments,
information provided by its insurance broker and third party administrator and
industry experience and trends. The accrual is an estimate and is subject to
change. Such change could be material to the Company's consolidated financial
statements. As of September 30, 2007, the Company had accrued $1.3 million in
estimated IBNR. The Company believes this is the best estimate of the amount of
IBNR relating to self-insured health benefit claims at September 30, 2007. Since
the Company's self-insured health benefits plan was initiated in May 2007, the
Company has not yet established historical trends which, in the future, may
cause costs to fluctuate with increases or decreases in the average number of
employees, changes in claims experience, and changes in the reporting and
payment processing time for claims.

      The Company has also purchased all risk umbrella liability policies with
aggregate limit of $19.0 million. The umbrella policies provide coverage in
excess of the primary layer and applicable retentions for all of its insured
liability risks, including general and professional liability and the workers'
compensation program.

      The Company finances various insurance policies at interest rates ranging
from 5.97% to 7.5% per annum. The Company incurred finance charges relating to
such policies of (in thousands) $36 and $91 during the three months ended
September 30, 2007 and 2006, respectively, and (in thousands) $89 and $179
during the six months ended September 30, 2007 and 2006, respectively. As of
September 30 and March 31, 2007, the accompanying condensed consolidated balance
sheets include the following balances relating to the financed insurance
policies (in thousands).

<TABLE>
                                                             September 30,       March 31,
                                                                  2007             2007
                                                             --------------   --------------
<S>                                                          <C>              <C>
Prepaid insurance                                            $        2,950   $        5,004
(Included in prepaid expenses and other current assets)

Accrued insurance premiums                                   $        1,918   $        3,808
(Included in other current liabilities)
</TABLE>

                                       23




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

      AGREEMENT FOR COMPENSATION - In connection with the close of the
Acquisition, the Company entered into an Agreement for Compensation Related to
the 999 Medical Office Building (the "Compensation Agreement") with PCHI, a
related party (Note 9). In the amended Asset Sale Agreement with Tenet, certain
medical office condominium units (the "Condo Units") were excluded from the
Company's Hospital Acquisition due to the condominium association of the Condo
Units having the right of first refusal to purchase such real property. As a
result, the Company's purchase price of the Hospitals from Tenet was reduced by
$5.0 million. Pursuant to the amended Asset Sale Agreement, upon the expiration
of the applicable right of first refusal, Tenet was to transfer title to the
Condo Units to the Company in exchange for consideration of $5.0 million, pro
rated if less than all of the Condo Units are transferred.

      Pursuant to the Compensation Agreement, the Company was to acquire title
to the Condo Units upon expiration of the applicable' right of first refusal and
then transfer such title to the Condo Units to PCHI. In the event of the
Company's failure to obtain title to the Condo Units, the Company was to pay to
PCHI a sum to be agreed upon between the Company, PCHI, and the owners of PCHI.
Tenet did not prevail in its efforts to transfer the units to the Company.

      As the financial statements of the related party entity, PCHI, a variable
interest entity, are included in the Company's accompanying consolidated
financial statements, management has determined that any future payment to PCHI
under the Compensation Agreement would reduce the Company's gain on sale of
assets to PCHI, which has been eliminated in consolidation. It is probable that
any funds transferred to PCHI will be distributed to its partners and reduce the
Company's liquidity. In connection with the Company's refinancing of its
outstanding debt in October 2007, the issues raised in relation to the
Compensation Agreement have been settled (Note 11).

      CLAIMS AND LAWSUITS - The Company and the Hospitals are subject to various
legal proceedings, most of which relate to routine matters incidental to
operations. The results of these claims cannot be predicted, and it is possible
that the ultimate resolution of these matters, individually or in the aggregate,
may have a material adverse effect on the Company's business (both in the near
and long term), financial position, results of operations, or cash flows.
Although the Company defends itself vigorously against claims and lawsuits and
cooperates with investigations, these matters (1) could require payment of
substantial damages or amounts in judgments or settlements, which individually
or in the aggregate could exceed amounts, if any, that may be recovered under
insurance policies where coverage applies and is available, (2) cause
substantial expenses to be incurred, (3) require significant time and attention
from the Company's management, and (4) could cause the Company to close or sell
the Hospitals or otherwise modify the way its business is conducted. The Company
accrues for claims and lawsuits when an unfavorable outcome is probable and the
amount is reasonably estimable.

      From time to time, health care facilities receive requests for information
in the form of a subpoena from licensing entities, such as the Medical Board of
California, regarding members of their medical staffs. Also, California state
law mandates that each medical staff is required to perform peer review of its
members. As a result of the performance of such peer reviews, action is
sometimes taken to limit or revoke an individual's medical staff membership and
privileges in order to assure patient safety. In August 2007, the Company
received such a subpoena from the Medical Board of California concerning a
member of the medical staff of one of the Company's facilities. The facility is
in the process of responding to the subpoena and is in the process of reviewing
the matter. Since the matter is in the early stage, the Company is not able to
determine the impact, if any, it may have on the Company's operations or
financial position.

      Approximately 16% of the Company's employees are represented by labor
unions as of September 30, 2007. On December 31, 2006, the Company's collective
bargaining agreements with SEIU and CNA expired. Negotiations with both the SEIU
and CNA led to agreements being reached on May 9, 2007, and October 16, 2007,
for the respective unions. Both contracts were ratified by their respective
memberships. The new SEIU Agreement will run until December 31, 2009, and the
Agreement with the CNA will run until February 28, 2011. Both Agreements have
"no strike" provisions and compensation caps which provide the Company with long
term compensation and workforce stability.


                                       24




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

      Both unions filed grievances under the prior collective bargaining
agreements, in connection with allegations the agreements obligated the Company
to contribute to Retiree Medical Benefit Accounts. The Company does not agree
with this interpretation of the agreements but has agreed to submit the matters
to arbitration. Under the new agreements negotiated this year, the Company has
agreed to meet with each Union to discuss how to create a vehicle which would
have the purpose of providing a retiree medical benefit, not to exceed one
percent (1%) of certain employee's payroll. CNA has also filed grievances
related to the administration of increases at one facility, change in pay
practice at one facility and several wrongful terminations. Those grievances are
still pending as of this date, but the Company does not anticipate resolution of
the arbitrations will have a material adverse effect on our results of
operations.

      On May 14, 2007, the Company filed suit in Orange County Superior Court
against three of the six members of its Board of Directors (as then constituted)
and also against the Company's largest shareholder, OC-PIN. The suit sought
damages, injunctive relief and the appointment of a provisional director. Among
other things, the Company alleges the defendants breached fiduciary duties owed
to the Company by putting their own economic interests above those of the
Company, its other shareholders, creditors, employees and the public-at-large.
The suit further alleges the defendants' then threatened attempts to change the
composition of the Company's management and Board (as then constituted)
threatened to trigger multiple "Events of Default" under the express terms of
the Company's existing credit agreements with its secured lenders.

      On May 17, 2007, OC-PIN filed a separate suit against the Company in
Orange County Superior Court. OC-PIN's suit sought injunctive relief and
damages. OC-PIN alleges the management issue referred to above, together with
issues related to monies claimed by OC-PIN, needed to be resolved before
completion of the Company's then pending refinancing of its secured debt. OC-PIN
further alleges that the Company's President failed to call a special
shareholders' meeting, thus denying OC-PIN the opportunity to elect a new member
to the Company's Board of Directors.

      Both actions have since been consolidated before one judge. On July 11,
2007, the Company's motion seeking the appointment of an independent provisional
director to fill a vacant seventh Board seat was granted. On the same date,
OC-PIN's motion for a mandatory injunction forcing the Company's President to
notice a special shareholders meeting was denied. All parties to the litigation
thereafter consented to the Court's appointment of the Hon. Robert C. Jameson,
retired, as a member of the Company's Board.

      The consolidation suits between the Company, on the one hand, and three
members of its former Board and OC-PIN are still pending. Given the favorable
rulings on July 11, 2007 and other factors, the Company continues to prosecute
its original action in hopes of recouping all, or at least a substantial
portion, of the economic losses caused by the defendants' alleged multiple
breaches of fiduciary duty and other wrongful conduct. The Company does not
anticipate the resolution of OC-PIN's ongoing claims for damages will have a
material adverse effect on its results of operations.

      In late May 2007, Western Medical Center, Santa Ana ("Medical Center") was
notified by a May 25, 2007 letter from CMS which had identified one case that
was a potential violation of the federal patient anti-dumping law (officially,
the Emergency Medical Treatment and Active Labor Act or EMTALA). In June 2007,
Lumetra, a Medicare quality improvement organization, notified Medical Center
that it was aiding CMS in its investigation of the same matter. Medical Center
has responded to CMS and Lumetra that its actions were appropriate and did not
violate EMTALA. The complaint from CMS and the notice from Lumetra are the first
steps in a determination by the Office of Inspector General ("OIG") of the U.S.
Department of Health and Human Services whether to seek enforcement action for a
violation of EMTALA. The potential sanctions which may be imposed by the OIG for
a violation of EMTALA are a civil money penalty up to $50.0 thousand for a
confirmed violation and possible exclusion from the Medicare and Medi-Cal
Programs. The Company has notified both CMS and Lumetra that it believes that a
violation of the EMTALA statutes and regulations did not occur nor should it be
subject to any civil money penalties. As a prophylactic matter it has also
reviewed and revised its policies and procedures regarding communication and
admission practices through the hospital's emergency department and has
conducted further EMTALA in service training.


                                       25




<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

NOTE 11 - SUBSEQUENT EVENTS

      Effective October 9, 2007, the Company and Medical Capital Corporation and
its affiliates (collectively "MCC") executed agreements to refinance MCC's
credit facilities with the Company aggregating up to $140.7 million in principal
amount (the "New Credit Facilities"). The New Credit Facilities replaced the
Company's previous credit facilities with MCC, which matured on March 2, 2007.
The Company had been operating under an Agreement to Forbear with MCC with
respect to the previous credit facilities.

      The New Credit Facilities consist of the following instruments:

      1.    An $80.0 million Credit Agreement, under which the Company issued a
            $45.0 million Term Note bearing a fixed interest rate of 9% in the
            first year and 14% after the first year, which was used to repay
            amounts owing under the Company's existing $50.0 million real estate
            term loan.

      2.    A $35.0 million Non-Revolving Line of Credit Note issued under the
            $80.0 million Credit Agreement, bearing a fixed interest rate of
            9.25% per year, which was used to repay amounts owing under the
            Company's existing $30.0 million line of credit, pay the origination
            fees on the other credit facilities and for working capital.

      3.    A $10.7 million Credit Agreement, under which the Company issued a
            $10.7 million Convertible Term Note bearing a fixed interest rate of
            9.25% per year, which was used to repay amounts owing under the
            Company's existing $10.7 million loan. The $10.7 million Convertible
            Term Note is convertible into common stock of the Company at $0.21
            per share anytime during the term of the Note.

      4.    A $50.0 million Revolving Credit Agreement, under which the Company
            issued a $50.0 million Revolving Line of Credit Note bearing a fixed
            interest rate of 24% per year (subject to reduction to 18% if the
            $45.0 million Real Estate Term Loan is repaid prior to its maturity)
            and an unused commitment fee of 0.50% per year, which was used to
            finance the repurchase of the Company's accounts receivable.

      Each of the above Credit Agreements and Notes (i) required a 1.5%
origination fee due at funding, (ii) matures in three years, (iii) requires
monthly payments of interest and repayment of principal upon maturity, (iv) are
collateralized by all of the assets of the Company and its subsidiaries and the
real estate underlying the Company's hospital facilities (which are owned by
PCHI and leased to the Company), and (v) are guaranteed by OC-PIN and West Coast
pursuant to separate Guaranty Agreements in favor of the lender. West Coast is a
member of PCHI.

      Concurrently with the execution of the New Credit Facilities, the Company
issued to an affiliate of MCC a five-year warrant to purchase the greater of
16.9 million shares of the Company's common stock or up to 4.95% of the
Company's common stock equivalents, as defined, at $0.21 per share (the "4.95%
Warrant"). In addition, the Company and MCC entered into Amendment No. 2 to
Common Stock Warrant, originally dated December 12, 2005, which entitles an
affiliate of MCC to purchase the greater of 26.1 million shares of the Company's
common stock or up to 31.09% of the Company's common stock equivalents (the
"31.09% Warrant"). Amendment No. 2 to the 31.09% Warrant extended the expiration
date of the Warrant to October 9, 2012, removed the condition that it only be
exercised if the Company is in default of its previous credit agreements, and
increased the exercise price to $0.21 per share unless the Company's stock
ceases to be registered under the Securities Exchange Act of 1934, as amended.
The 31.09% Warrant was previously referred to as the December Note Warrant under
the prior financing arrangements.

      As a condition of the New Credit Facilities, the Company entered into an
Amended and Restated Triple Net Hospital Building Lease with PCHI (the "Amended
Lease"). The Amended Lease terminates on the 25-year anniversary of the original
lease (March 8, 2005) (and grants the Company the right to renew for one
additional 25-year period) and requires annual base rental payments of $8.3
million (but until the Company refinances its $50.0 million Revolving Line of
Credit Loan with a stated interest rate less than 14% per annum or PCHI
refinances the Real Estate Loan, the annual base rental payments are reduced to
$7.1 million). In addition, the Company may offset against its rental payments
owed to PCHI interest payments that it makes to MCC under certain of its
indebtedness discussed above. The Amended Lease also gives PCHI sole possession
of the medical office buildings located at 1901/1905 North College Avenue, Santa
Ana, California (the "Kindred Property") that are unencumbered by any claims by
or tenancy of the Company.


                                       26
<PAGE>

                      INTEGRATED HEALTHCARE HOLDINGS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007
                                   (UNAUDITED)

      Concurrently with the execution of the Amended Lease, the Company, PCHI,
Ganesha, and West Coast entered into a Settlement Agreement and Mutual Release
(the "Settlement Agreement") whereby the Company agreed to pay to PCHI $2.5
million as settlement for unpaid rents specified in the Settlement Agreement,
relating to the Kindred Property, and for compensation relating to the medical
office buildings located at 999 North Tustin Avenue in Santa Ana, California,
under a previously executed Agreement to Compensation.

      As a result of the Company's refinancing, the remaining 24.9 million
warrants (Note 5) held by Dr. Chaudhuri and Mr. Thomas became exercisable on the
October 9, 2007 effective date of the refinancing and will result in an
estimated $1.5 million in warrant expense at such date.

      On October 10, 2007, the Board of Directors approved the granting of
options with the right to purchase an aggregate of 1,750 thousand shares of the
Company's common stock to members of the Board pursuant to the Company's 2006
Stock Incentive Plan. The grant price approved on that date is $0.18 per share.
The options are subject to various vesting periods and will expire seven years
from the date of grant.

      On October 31, Memorial Health Services ("MHS"), a not-for-profit health
care system with hospitals in Los Angeles and Orange Counties, announced that it
selected the Company to purchase its 224-bed facility in Anaheim, California.
The Company's bid was $68.0 million, which will be financed completely through
new debt. The Company is also committing to a capital investment of $28.7
million into the hospital following the close of the sale. Subject to the
execution of a definitive agreement, MHS anticipates filing the notice of the
sale with the California Attorney General's office on or about December 1, 2007.


                                       27




<PAGE>

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS.

FORWARD-LOOKING INFORMATION

      This Quarterly Report on Form 10-Q contains forward-looking statements, as
that term is defined in the Private Securities Litigation Reform Act of 1995.
These statements relate to future events or our future financial performance. In
some cases, you can identify forward-looking statements by terminology such as
"may," "will," "should," "expects," "plans," "anticipates," "believes,"
"estimates," "predicts," "potential" or "continue" or the negative of these
terms or other comparable terminology. These statements are only predictions and
involve known and unknown risks, uncertainties and other factors, including the
risks discussed under the caption "Risk Factors" in our Annual Report on Form
10-K filed on July 16, 2007 that may cause our Company's or our industry's
actual results, levels of activity, performance or achievements to be materially
different from those expressed or implied by these forward-looking statements.

      Although we believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee future results, levels of
activity, performance or achievements. Except as may be required by applicable
law, we do not intend to update any of the forward-looking statements to conform
these statements to actual results.

      As used in this report, the terms "we," "us," "our," "the Company,"
"Integrated Healthcare Holdings" or "IHHI" mean Integrated Healthcare Holdings,
Inc., a Nevada corporation, unless otherwise indicated.

OVERVIEW

      On March 8, 2005, the Company completed its acquisition (the
"Acquisition") of four Orange County, California Hospitals and associated real
estate, including: (i) 282-bed Western Medical Center - Santa Ana, CA; (ii)
188-bed Western Medical Center - Anaheim, CA; (iii) 178-bed Coastal Communities
Hospital in Santa Ana, CA; and (iv) 114-bed Chapman Medical Center in Orange, CA
(collectively, the "Hospitals") from Tenet Healthcare Corporation ("Tenet"). The
Hospitals were assigned to four wholly owned subsidiaries of the Company formed
for the purpose of completing the Acquisition. The Company also acquired the
following real estate, leases and assets associated with the Hospitals: (i) a
fee interest in the Western Medical Center at 1001 North Tustin Avenue, Santa
Ana, CA, a fee interest in the administration building at 1301 North Tustin
Avenue, Santa Ana, CA, certain rights to acquire condominium suites located in
the medical office building at 999 North Tustin Avenue, Santa Ana, CA, and the
business known as the West Coast Breast Cancer Center; (ii) a fee interest in
the Western Medical Center at 1025 South Anaheim Blvd., Anaheim, CA; (iii) a fee
interest in the Coastal Communities Hospital at 2701 South Bristol Street, Santa
Ana, CA, and a fee interest in the medical office building at 1901 North College
Avenue, Santa Ana, CA; (iv) a lease for the Chapman Medical Center at 2601 East
Chapman Avenue, Orange, CA, and a fee interest in the medical office building at
2617 East Chapman Avenue, Orange, CA; and (v) equipment and contract rights. At
the closing of the Acquisition, the Company transferred all of the fee interests
in the acquired real estate (the "Hospital Properties") to Pacific Coast
Holdings Investment, LLC ("PCHI"), a company owned directly or indirectly by two
of the Company's largest shareholders.

SIGNIFICANT CHALLENGES

      COMPANY - Our acquisition involved significant cash expenditures, debt
incurrence and integration expenses that has seriously strained our financial
condition. If we are required to issue equity securities to raise additional
capital, existing stockholders will likely be substantially diluted, which could
affect the market price of our stock.

      INDUSTRY - Our Hospitals receive a substantial portion of their revenues
from Medicare and Medicaid. The healthcare industry is experiencing a strong
trend toward cost containment, as the government seeks to impose lower
reimbursement and resource utilization group rates, limit the scope of covered
services and negotiate reduced payment schedules with providers. These cost
containment measures generally have resulted in a reduced rate of growth in the
reimbursement for the services that we provide relative to the increase in our
cost to provide such services.

      Changes to Medicare and Medicaid reimbursement programs have limited, and
are expected to continue to limit, payment increases under these programs. Also,
the timing of payments made under the Medicare and Medicaid programs is subject
to regulatory action and governmental budgetary constraints resulting in a risk
that the time period between submission of claims and payment could increase.
Further, within the statutory framework of the Medicare and Medicaid programs, a
substantial number of areas are subject to administrative rulings and
interpretations which may further affect payments.

                                       28

<PAGE>

      Our business is subject to extensive federal, state and, in some cases,
local regulation with respect to, among other things, participation in the
Medicare and Medicaid programs, licensure and certification of facilities, and
reimbursement. These regulations relate, among other things, to the adequacy of
physical property and equipment, qualifications of personnel, standards of care,
government reimbursement and operational requirements. Compliance with these
regulatory requirements, as interpreted and amended from time to time, can
increase operating costs and thereby adversely affect the financial viability of
our business. Because these regulations are amended from time to time and are
subject to interpretation, we cannot predict when and to what extent liability
may arise. Failure to comply with current or future regulatory requirements
could also result in the imposition of various remedies including (with respect
to inpatient care) fines, restrictions on admission, denial of payment for all
or new admissions, the revocation of licensure, decertification, imposition of
temporary management or the closure of a facility or site of service.

      We are subject to periodic audits by the Medicare and Medicaid programs,
which have various rights and remedies against us if they assert that we have
overcharged the programs or failed to comply with program requirements. Rights
and remedies available to these programs include repayment of any amounts
alleged to be overpayments or in violation of program requirements, or making
deductions from future amounts due to us. These programs may also impose fines,
criminal penalties or program exclusions. Other third-party payer sources also
reserve rights to conduct audits and make monetary adjustments in connection
with or exclusive of audit activities.

         The healthcare industry is highly competitive. We compete with a
variety of other organizations in providing medical services, many of which have
greater financial and other resources and may be more established in their
respective communities than we are. Competing companies may offer newer or
different centers or services than we do and may thereby attract patients or
customers who are presently patients, customers or are otherwise receiving our
services. An increasing trend in malpractice litigation claims, rising costs of
malpractice litigation, losses associated with these malpractice lawsuits and a
constriction of insurers have caused many insurance carriers to raise the cost
of insurance premiums or refuse to write insurance policies for hospital
facilities. Also, a tightening of the reinsurance market has affected property,
auto and excess liability insurance carriers. Accordingly, the costs of all
insurance premiums have increased.

         An increasing trend in malpractice litigation claims, rising costs of
malpractice litigation, losses associated with these malpractice lawsuits and a
constriction of insurers have caused many insurance carriers to raise the cost
of insurance premiums or refuse to write insurance policies for hospital
facilities. Also, a tightening of the reinsurance market has affected property,
auto and excess liability insurance carriers. Accordingly, the costs of all
insurance premiums have increased.

      We receive all of our inpatient services revenue from operations in Orange
County, California. The economic condition of this market could affect the
ability of our patients and third-party payers to reimburse us for our services,
through its effect on disposable household income and the tax base used to
generate state funding for Medicaid programs. An economic downturn, or changes
in the laws affecting our business in our market and in surrounding markets,
could have a material adverse effect on our financial position, results of
operations and cash flows.

LIQUIDITY AND CAPITAL RESOURCES

      The accompanying consolidated financial statements have been prepared on a
going concern basis, which contemplates the realization of assets and settlement
of obligations in the normal course of business. The Company incurred a net loss
of $4,649 thousand during the six months ended September 30, 2007 and has a
working capital deficit of $89,584 thousand at September 30, 2007. The Company
refinanced its outstanding debt in October 2007, see "REFINANCING."

      These factors, among others, indicate a need for the Company to take
action to operate its business as a going concern. There is no assurance that
the Company will be successful in improving reimbursements or reducing operating
expenses.

      Management has also been working on improvements in several areas that the
Company believes will improve cash flow from operations:

      1.    Net operating revenues: Due primarily to the impact of improved
            contracts, commercial, managed care, and other patient revenues
            improved $5.8 million during the six months ended September 30, 2007
            compared to the same period in 2006.


                                       29




<PAGE>

            Net collectible revenues (net operating revenues less provision for
            doubtful accounts) for the six months ended September 30, 2007 and
            2006 were $166.6 million and $157.5 million, respectively. During
            the six months ended September 30, 2007 and 2006, the Company
            received $3.0 million and $3.5 million lump sum awards from the
            State MediCal unit, respectively. Adjusting for this, revenues grew
            by 3.3%.

            The Hospitals serve a disproportionate number of indigent patients
            and receive governmental revenues and subsidies in support of care
            for these patients. Governmental revenues include payments for
            Medicaid, Medicaid DSH, and Orange County, CA (CalOptima).
            Governmental revenues increased $0.7 million for the six months
            ended September 30, 2007 compared to the same period in 2006.

            Inpatient admissions decreased by 0.3% to 13,835 for the six months
            ended September 30, 2007 compared to 13,871 for the same period in
            2006. This was primarily attributable to the termination of
            CalOptima capitation agreements. This resulted in a net reduction in
            capitation revenues of $0.9 million compared to the six months ended
            September 30, 2006. This was offset by a $8.6 million increase in
            CalOptima fee-for-service revenues under continuing agreements. The
            net difference in revenues is offset by a corresponding increase in
            direct operating expenses.

      2.    Operating expenses: Management is working aggressively to reduce
            cost without reduction in service levels. These efforts have in
            large part been offset by inflationary pressures. Operating expenses
            before interest and warrants for the six months ended September 30,
            2007 were $1.0 million, or 0.5%, higher than for the same period in
            2006. Due to favorable claims experience the Company has secured
            lower rates for insurance for the year ending March 31, 2008 for
            Risk and Workers Compensation. The estimated annual savings are
            projected to be $3.5 million.

            Financing costs: The Company completed the Acquisition of the
            Hospitals with a high level of debt financing. Additionally, the
            Company entered into an Accounts Purchase Agreement and is incurring
            significant discounts on the sale of accounts receivable. As
            described in the notes to the consolidated financial statements, the
            largest investor was unable to meet all the commitments under the
            stock purchase agreement. As a result, the Company incurred
            additional interest costs from default rates and higher than planned
            borrowings. Effective October 9, 2007, the Company entered into new
            financing arrangements with Medical Capital Corporation and its
            affiliates (see "REFINANCING").

            The terms of the new financing are expected to reduce the Company's
            cost of capital by $4.7 million in the first year.

      The foregoing analysis presumes that capital expenditures to replace
equipment can be kept to an immaterial amount in the short term. It is the
intent of management to fund future capital expenditures from operations.

      REFINANCING - Effective October 9, 2007, the Company and Medical Capital
Corporation and its affiliates (collectively "MCC") executed agreements to
refinance MCC's credit facilities with the Company aggregating up to
$140.7 million in principal amount (the "New Credit Facilities"). The New Credit
Facilities replaced the Company's previous credit facilities with MCC, which
matured on March 2, 2007. The Company had been operating under an Agreement to
Forbear with MCC with respect to the previous credit facilities.

      The New Credit Facilities consist of the following instruments:

      1.    An $80.0 million Credit Agreement, under which the Company issued a
            $45.0 million Term Note bearing a fixed interest rate of 9% in the
            first year and 14% after the first year, which was used to repay
            amounts owing under the Company's existing $50.0 million real estate
            term loan.

      2.    A $35.0 million Non-Revolving Line of Credit Note issued under the
            $80.0 million Credit Agreement, bearing a fixed interest rate of
            9.25% per year, which was used to repay amounts owing under the
            Company's existing $30.0 million line of credit, pay the origination
            fees on the other credit facilities and for working capital.

      3.    A $10.7 million Credit Agreement, under which the Company issued a
            $10.7 million Convertible Term Note bearing a fixed interest rate of
            9.25% per year, which was used to repay amounts owing under the
            Company's existing $10.7 million loan. The $10.7 million Convertible
            Term Note is convertible into common stock of the Company at $0.21
            per share at any time during the term of the Note.


                                       30
<PAGE>

      4.    A $50.0 million Revolving Credit Agreement, under which the Company
            issued a $50.0 million Revolving Line of Credit Note bearing a fixed
            interest rate of 24% per year (subject to reduction to 18% if the
            $45.0 million Real Estate Term Loan is repaid prior to its maturity)
            and an unused commitment fee of 0.50% per year, which was used to
            repurchase all of the Company's accounts receivable.

      Each of the above Credit Agreements and Notes (i) required a 1.5%
origination fee due at funding, (ii) matures in three years, (iii) requires
monthly payments of interest and repayment of principal upon maturity, (iv) are
collateralized by all of the assets of the Company and its subsidiaries and the
real estate underlying the Company's hospital facilities (which are owned by
PCHI and leased to the Company), and (v) are guaranteed by Orange County
Physicians Investment Network, LLC ("OC-PIN") and West Coast Holdings, LLC
("West Coast") pursuant to separate Guaranty Agreements in favor of the lender.
West Coast is a member of PCHI.

      Concurrently with the execution of the New Credit Facilities, the Company
issued to an affiliate of MCC a five-year warrant to purchase the greater of
16.9 million shares of the Company's common stock or up to 4.95% of the
Company's common stock equivalents, as defined, at $0.21 per share (the "4.95%
Warrant"). In addition, the Company and MCC entered into Amendment No. 2 to
Common Stock Warrant, originally dated December 12, 2005, which entitles an
affiliate of MCC to purchase the greater of 26.1 million shares of the Company's
common stock or up to 31.09% of the Company's common stock equivalents (the
"31.09% Warrant"). Amendment No. 2 to the 31.09% Warrant extended the expiration
date of the Warrant to October 9, 2012, removed the condition that it only be
exercised if the Company is in default of its previous credit agreements, and
increased the exercise price to $0.21 per share unless the Company's stock
ceases to be registered under the Securities Exchange Act of 1934, as amended.
The 31.09% Warrant was previously referred to as the December Note Warrant under
the prior financing arrangements.

      As a condition of the New Credit Facilities, the Company entered into an
Amended and Restated Triple Net Hospital Building Lease with PCHI (the "Amended
Lease"). The Amended Lease terminates on the 25-year anniversary of the original
lease (March 8, 2005) (and grants the Company the right to renew for one
additional 25-year period) and requires annual base rental payments of $8.3
million (but until the Company refinances its $50.0 million Revolving Line of
Credit Loan with a stated interest rate less than 14% per annum or PCHI
refinances the Real Estate Loan, the annual base rental payments are reduced to
$7.1 million). In addition, the Company may offset against its rental payments
owed to PCHI interest payments that it makes to MCC under certain of its
indebtedness discussed above. The Amended Lease also gives PCHI sole possession
of the medical office buildings located at 1901/1905 North College Avenue, Santa
Ana, California (the "Kindred Property") that are unencumbered by any claims by
or tenancy of the Company.

      Concurrently with the execution of the Amended Lease, the Company, PCHI,
Ganesha Realty, LLC, and West Coast entered into a Settlement Agreement and
Mutual Release (the "Settlement Agreement") whereby the Company agreed to pay to
PCHI $2.5 million as settlement for unpaid rents specified in the Settlement
Agreement, relating to the Kindred Property, and for compensation relating to
the medical office buildings located at 999 North Tustin Avenue in Santa Ana,
California, under a previously executed Agreement to Compensation.

      As a result of the Company's refinancing, the remaining 24.9 million
warrants (Note 5 to the condensed consolidated financial statements) held by Dr.
Chaudhuri and Mr. Thomas became exercisable on the October 9, 2007 effective
date of the refinancing.

      ACQUISITION DEBT - Effective March 3, 2005, in connection with the
Acquisition, the Company and its subsidiaries collectively entered into a credit
agreement (the "Credit Agreement") with Medical Provider Financial Corporation
II ("the Lender"), whereby the Company obtained initial financing in the form of
a loan with interest at the rate of 14% per annum in the amount of $80.0 million
of which $30.0 million is in the form of a non revolving Line of Credit and
$50.0 million (less $5.0 million repayment on December 12, 2005) is in the form
of an Acquisition Loan (collectively, the "Obligations"). The Company used the
proceeds from the $50.0 million Acquisition Loan and $3.0 million from the Line
of Credit to complete the Acquisition. The Acquisition Loan and Line of Credit
are secured by a lien on substantially all of the assets of the Company and its
subsidiaries, including without limitation, a pledge of the capital stock by the
Company in its wholly owned Hospitals. Effective October 9, 2007, this debt, in
the amount of $72.3 million, was refinanced (see "REFINANCING").


                                       31




<PAGE>

      SECURED SHORT TERM NOTE - On December 12, 2005, the Company entered into a
credit agreement with the lender, whereby the lender loaned the Company $10.7
million. This was primarily due to the Company's inability to secure the
required equity pursuant to its Stock Purchase Agreement with OC-PIN. The $10.7
million short term note matured on December 12, 2006 and was extended through
March 2, 2007. The note is secured by substantially all the assets of the
Company and is further collateralized by the December Note Warrant which is
exercisable by the lender in the event of default by the Company. The $10.7
million note is current, due and payable, the underlying warrant is exercisable
as the Company received a formal notice of default from its lender on June 18,
2007. The Short Term Note is subject to the Forbearance Agreement. Effective
October 9, 2007, this note was refinanced (see "REFINANCING").

      LONG TERM LEASE COMMITMENT WITH VARIABLE INTEREST ENTITY - The Company
sold $5.0 million in limited partnership interests to finance the Acquisition to
PCHI and guaranteed the Company's Acquisition Loan. Concurrent with the close on
the Acquisition, the Company sold substantially all of the real property
acquired in the Acquisition to PCHI. PCHI is a related party entity that is
affiliated with the Company through common ownership and control. Additionally,
a gain of $4,433 thousand arising from the Company's sale of the real property
of the Hospitals to PCHI has been eliminated in the accompanying condensed
consolidated financial statements so as to record the land and buildings at the
Company's cost. Upon such sale, the Company entered into a 25 year lease
agreement with PCHI involving substantially all of the real property acquired in
the Acquisition. The commitment on this lease agreement is approximately $256.0
million over the remainder of the lease term, subject to CPI adjustments and
prevailing real estate values for similar use properties.

      The Company remains primarily liable under the Acquisition Loan note
notwithstanding its guarantee by PCHI, and this note is cross collateralized by
substantially all of the Company's assets and all of the real property of the
Hospitals. All of the Company's operating activities are directly affected by
the real property that was sold to PCHI. Given these factors, the Company has
indirectly guaranteed the indebtedness of PCHI. The Company is standing ready to
perform on the Acquisition Loan should PCHI not be able to perform and has
undertaken a contingent obligation to make future payments if those triggering
events or conditions occur.

      ACCOUNTS PURCHASE AGREEMENT - In March 2005, the Company entered into an
Accounts Purchase Agreement (the "APA") for a minimum of two years with Medical
Provider Financial Corporation I, an unrelated party (the "Buyer"). The Buyer is
an affiliate of the Lender (see "ACQUISITION DEBT"). The APA provides for the
sale of 100% of the Company's eligible accounts receivable, as defined, without
recourse. The APA provides for the Company to provide billing and collection
services, maintain the individual patient accounts, and resolve any disputes
that arise between the Company and the patient or other third party payer for no
additional consideration.

      The accounts receivable are sold weekly based on separate bills of sale
for each Hospital. The purchase price is comprised of two components, the
Advance Rate Amount and the Deferred Purchase Price Receivable amount, as
defined. The Advance Rate Amount is based on the Buyer's appraisal of accounts
receivable accounts. The Buyer's appraisal is developed internally by the Buyer
and does not necessarily reflect the net realizable value or the fair value of
the accounts receivable sold. At the time of sale, the Buyer advances 95% of the
Buyer's appraised value (the "95% Advance) on eligible accounts to the Company
and holds the remaining 5% as part of the security reserve funds on sold
accounts (the "Security Reserve Funds"), which is non-interest bearing. Except
in the case of a continuing default, the Security Reserve Funds can not exceed
15% (the "15% Cap") of the aggregate Advance Rate Amount of the open purchases.
The Company is charged a "purchase discount" (the "Transaction Fee") of 1.35%
per month of the Advance Rate Amount of each tranche of accounts receivable
accounts purchased until closed based on application of cash collections up to
the Advance Rate Amount for that tranche, at which time the Buyer deducts the
Transaction Fee from the Security Reserve Funds. The Company holds cash
collected in its lockbox in a fiduciary role for the Buyer and records the cash
as part of Security Reserve Funds. Collections are applied by the Buyer on a
dollar value basis, not by specific identification, to the respective Hospital's
most aged open purchase until the tranche is closed. The APA further provides
that if the amount collected (as to each account purchased within 180 days of
the billing date on any account, including substitute assets, purchased by
Buyer) is less than the amount of its Adjusted Value, as defined, then such
seller shall remit to Buyer the amount of such difference between the Adjusted
Value of the account and the amount actually collected on such account by Buyer
as the repurchase price for such account. If the Seller fails to repurchase such
accounts, the Buyer shall deduct from the Advance Rate Amount and Deferred
Purchase Price otherwise payable for all accounts with respect to any purchase,
an amount equal to the Adjusted Value of such uncollected account less the
deferred portion of the purchase price thereof, thereby closing the tranche.
These provisions have not been applied in the contract to date due to the timely
closure of tranches.


                                       32




<PAGE>

      Collections in excess of the Advance Rate Amount are credited by the Buyer
to Security Reserve Funds and ultimately released to the Company to pay down the
Deferred Purchase Price Receivable. The Deferred Purchase Price Receivable
approximates fair value and represents amounts the Company expects to collect,
based on regulations, contracts, and historical collection experience, in excess
of the Advance Rate Amount. In determining the fair value of the Deferred
Purchase Price Receivable recorded upon sales of accounts receivable accounts
under the APA, the key assumption used is the application of a short-term
discount rate. If the discount rate applied increased by 10%, the adverse effect
on the Deferred Purchase Price Receivable and related loss on sale of accounts
receivable would be insignificant. The Deferred Purchase Price Receivable is
unsecured.

      From inception of the APA through September 30, 2007, the Buyer has
advanced $629.3 million to the Company through the APA. In addition, the Company
has received $54.5 million in reserve releases from inception through September
30, 2007. Payments posted on sold receivables from inception have approximated
$690.6 million. Advances net of payment and adjustment activity, cumulatively
through September 30 and March 31, 2007 were ($7.7) million and $7.0 million,
respectively. Transaction Fees incurred for the same periods were $11.5 million
and $9.3 million, respectively.

      The Company records estimated Transaction Fees and estimated servicing
liability related to the sold accounts receivable at the time of sale. The
Company incurred a loss on sale of accounts receivable of (in thousands) $4,997
and $4,969 for the six months ended September 30, 2007 and 2006.

      DECEMBER NOTE WARRANT - In accordance with SFAS No. 150, the Company has
included the December Note value of $10.7 million in warrant liabilities,
current, in the accompanying condensed consolidated balance sheets as of
September 30 and March 31, 2007 and recomputed the fair value in accordance with
SFAS No. 133 at each reporting date. Under the terms of the December Credit
Agreement, any proceeds from the sale of stock received under the December Note
Warrant that are in excess of the December Note and related issuance costs are
to be paid to the Company as paid in capital. Accordingly, the fair value of the
December Note Warrant would contractually continue to be $10.7 million (plus any
issuance and exercise costs, which are considered immaterial).

      At September 30 and March 31, 2007, the estimated potential number of
shares was calculated using the market price and $10.7 million liability of the
Company. The estimated number of shares was 53.5 million and 33.4 million,
respectively. The maximum number of share issuable in the event of default in
accordance with the December Note Warrant agreement however, is the greatest of:
(1) 26.1 million Shares of Common Stock, (2) Shares representing 31.09% of all
Common Stock and Common Stock Equivalents of the Company, or 61.9 million at
September 30 and March 31, 2007, respectively, and (3) the fair market value of
Shares of Common Stock equal to the amount of the $10.7 million loan not repaid
at maturity or default of such Loan, plus any accrued and unpaid interest
thereon, Lender's fees, costs and expenses, and attorneys' fees. Any amounts
received by the lender from the sale of stock they received when they exercise
the warrants in excess of that required to retire the $10.7 million debt would
be paid to the Company as additional paid in capital.

      RESTRUCTURING WARRANTS - The Company entered into a Rescission,
Restructuring and Assignment Agreement with Dr. Kali Chaudhuri and Mr. William
Thomas on January 27, 2005 (the "Restructuring Agreement"). Pursuant to the
Restructuring Agreement, the Company issued warrants to purchase up to 74.7
million shares of the Company's common stock (the "Restructuring Warrants") to
Dr. Chaudhuri and Mr. Thomas (not to exceed 24.9% of the Company's fully diluted
capital stock at the time of exercise). In addition, the Company amended the
Real Estate Option to provide for Dr. Chaudhuri's purchase of a 49% interest in
PCHI for $2.45 million.

      The Restructuring Warrants were exercisable beginning January 27, 2007 and
expire on July 27, 2008. The exercise price for the first 43 million shares
purchased under the Restructuring Warrants is $0.003125 per share, and the
exercise or purchase price for the remaining 31.7 million shares is $0.078 per
share if exercised between January 27, 2007 and July 26, 2007, $0.11 per share
if exercised between July 27, 2007 and January 26, 2008, and $0.15 per share
thereafter. In accordance with FAS No. 133, these warrants are accounted for as
liabilities and are revalued at each reporting date, and the changes in fair
value are recorded as change in fair value of derivative on the consolidated
statement of operations.


                                       33




<PAGE>

      During February 2007, Dr. Chaudhuri and Mr. Thomas submitted an exercise
under these warrants to the Company. At March 31, 2007 the Company recorded the
issuance of 28.7 million net shares under this exercise following resolution of
certain legal issues relating thereto. The issuance of these shares resulted in
an addition to additional paid in capital and to common stock totaling $9,199
thousand. These shares were issued to Dr. Chaudhuri and Mr. Thomas on July 2,
2007. The shares pursuant to this exercise were recorded as issued and
outstanding at March 31, 2007. Additionally, the remaining liability was
revalued at March 31, 2007 in the amount of $4.2 million relating to potential
shares (20.8 million shares) which could be issued, if the December Note warrant
was to become issuable, which occurred on June 13, 2007 upon receipt of a notice
of default from the Lender.

      On July 2, 2007, the Company accepted, due to the default and subsequent
vesting of the December Note Warrant, an additional exercise under the
anti-dilution provisions the Restructuring Warrant Agreement by Dr. Chaudhuri
and Mr. Thomas. The exercise resulted in additional shares issuable of 20.8
million shares for consideration of $576 thousand in cash. The effect of this
exercise resulted in additional warrant expense for the year ended March 31,
2007 of $693 thousand, which was accrued based on the transaction as of March
31, 2007.

      The Company recorded a change in the fair value of derivative of (in
thousands) $0 and a gain of $779 for the three months ended September 30, 2007
and 2006, respectively, and (in thousands) $0 and a gain of $5,104 for the six
months ended September 30, 2007 and 2006, respectively. The related warrant
liability of $4.2 million (as of March 31, 2007) was reclassified to additional
paid in capital when the 20.8 million shares were issued to Dr. Chaudhuri and
Mr. Thomas in July 2007.

      As a result of the Company's refinancing, effective October 9, 2007 (see
"REFINANCING"), the remaining 24.9 million warrants held by Dr. Chaudhuri and
Mr. Thomas became exercisable. Accordingly, during the three months ending
December 31, 2007, the Company will record estimated common stock warrant
expense (in thousands) of $1,500.

      COMMITMENTS AND CONTINGENCIES - The State of California has imposed new
hospital seismic safety requirements. The Company operates four hospitals
located in an area near active earthquake faults. Under these new requirements,
the Company must meet stringent seismic safety criteria in the future, and, must
complete one set of seismic upgrades to the facilities by January 1, 2013. This
first set of upgrades is expected to require the Company to incur substantial
seismic retrofit costs. There are additional requirements that must be complied
with by 2030. The Company is currently estimating the costs of meeting these
requirements; however a total estimated cost has not yet been determined.

RESULTS OF OPERATIONS

      The following table sets forth, for the three and six months ended
September 30, 2007 and 2006, our consolidated statements of operations expressed
as a percentage of net operating revenues.

<TABLE>
                                                                 Three months ended                  Six months ended
                                                                   September 30,                       September 30,
                                                         --------------------------------    --------------------------------
                                                              2007              2006              2007              2006
                                                         --------------    --------------    --------------    --------------
<S>                                                              <C>               <C>               <C>               <C>
Net operating revenues                                           100.0%            100.0%            100.0%            100.0%

Operating expenses:
  Salaries and benefits                                           53.6%             56.8%             54.9%             54.1%
  Supplies                                                        12.9%             14.4%             13.5%             13.8%
  Provision for doubtful accounts                                  7.7%             10.7%              8.6%             10.7%
  Other operating expenses                                        18.2%             19.5%             18.8%             19.8%
  Loss on sale of accounts receivable                              2.5%              3.1%              2.7%              2.8%
  Depreciation and amortization                                    0.8%              0.8%              0.9%              0.8%
                                                         --------------    --------------    --------------    --------------
  Total operating expenses                                        95.7%            105.3%             99.4%            102.0%
                                                         --------------    --------------    --------------    --------------

Operating income (loss)                                            4.3%             (5.3%)             0.6%             (2.0%)
Other expense:
  Interest expense, net                                           (3.2%)            (4.0%)            (3.4%)            (3.8%)
  Change in fair value of derivative                               0.0%              0.9%              0.0%              2.9%
                                                         --------------    --------------    --------------    --------------
                                                                  (3.2%)            (3.1%)            (3.4%)            (0.9%)
                                                         --------------    --------------    --------------    --------------

Income (loss) before minority interest                             1.1%             (8.4%)            (2.8%)            (2.9%)
Minority interest in variable interest entity                      0.1%              0.2%              0.1%              0.2%
                                                         --------------    --------------    --------------    --------------
Net income (loss)                                                  1.2%             (8.2%)            (2.7%)            (2.7%)
                                                         ==============    ==============    ==============    ==============
</TABLE>


                                       34




<PAGE>

CONSOLIDATED RESULTS OF OPERATIONS - THREE MONTHS ENDED SEPTEMBER 30, 2007 and
2006

NET OPERATING REVENUES

      Net operating revenues for the three months ended September 30, 2007
increased 11.8% compared to the same period in 2006. Admissions for the three
months ended September 30, 2007 increased 1.7% compared to the same period in
2006. Revenue per admission improved by 9.9% during the three months ended
September 30, 2007. DSH and CMAC revenues represented 2.7% of the increase
including a lump sum amendment to the CMAC agreement for $3.0 million in the
three months ended September 30, 2007. The underlying mix of patients improved
during the three months ended September 30, 2007 and 2006, with a 11.6% decline
in uninsured patients. Based on average revenue for comparable services from all
other payers, revenues foregone under the charity policy, including indigent
care accounts, for the three months ended September 30, 2007 and 2006 were $2.0
million and $2.0 million, respectively.

      Essentially all net operating revenues come from external customers. The
largest payers are the Medicare and Medicaid programs accounting for 67.7% and
63.2% of the net operating revenues for the three months ended September 30,
2007 and 2006, respectively.

      Although not a GAAP measure, the Company defines "Net Collectable
Revenues" as net operating revenues less provision for doubtful accounts. This
eliminates the distortion caused by the changes in patient account
classification. Excluding the $3.0 million one time grant referred to above, Net
Collectable Revenues were $85.0 million and $76.2 million for the three months
ended September 30, 2007 and 2006, respectively, an increase of $8.8 million, or
9.8% per admission.

OPERATING EXPENSES

      Operating expenses for the three months ended September 30, 2007 increased
to $91.3 million from $89.9 million, an increase of $1.4 million or 1.6%
compared to the same period in 2006. The increase in operating expenses was
primarily the result of the increase in admissions.

      Salaries and benefits increased $2.7 million (5.5%) for the three months
ended September 30, 2007 compared to the same period in 2006. Other operating
expenses increased $0.7 million for the three months ended September 30, 2007
compared to the same period in 2006. Both salaries and benefits and other
operating expenses decreased as a percentage of revenue (see table) primarily
due to the additional $3.0 million in CMAC revenue referred to above.

      The provision for doubtful accounts for the three months ended September
30, 2007 decreased to $7.4 million from $9.2 million or 19.6% compared to the
same period in 2006. The decrease in the provision for doubtful accounts for the
three months ended September 30, 2007 is primarily due to improvements in
recoveries of bad debt and a reduction in unfunded patients compared to the same
period in 2006.

      The loss on sale of accounts receivable for the three months ended
September 30, 2007 decreased to $2.4 million from $2.6 million, a decrease of
$0.2 million or 7.7%. The decrease in the loss on sale of accounts receivable
for the three months ended September 30, 2007 was primarily due to decreased
cost of servicing the accounts.

OPERATING INCOME (LOSS)

      Operating income for the three months ended September 30, 2007 was $4.1
million compared to a loss of $4.6 million for the three months ended September
30, 2006. The increase in operating income in 2007 is primarily due to increased
volumes, improved payer mix, supplemental funding and decrease in the provision
for doubtful accounts.

OTHER EXPENSE, NET

      For the three months ended September 30, 2007 there was no change in the
fair value of warrants. For the three months ended September 30, 2006 there was
a $0.8 million reduction in the fair value of warrants resulting in a gain.

      Interest expense for the three months ended September 30, 2007 was
substantially unchanged compared to the same period in 2006.

NET INCOME (LOSS)

      Net income for the three months ended September 30, 2007 was $1.1 million
compared to a net loss of $7.0 million for the same period in 2006. The change
in net results for the three months ended September 30, 2007 was primarily due
to the increase in net operating revenues.


                                       35




<PAGE>

CONSOLIDATED RESULTS OF OPERATIONS - SIX MONTHS ENDED SEPTEMBER 30, 2007 and
2006

NET OPERATING REVENUES

      Net operating revenues for the six months ended September 30, 2007
increased 3.3% compared to the same period in 2006. During the six months ended
September 30, 2007 and 2006, the Company was granted $3.0 million and $3.5
million, respectively, for indigent care. Admissions for the six months ended
September 30, 2007 decreased 0.3% compared to the same period in 2006. Revenue
per admission improved by 3.6% during the six months ended September 30, 2007.
The underlying mix of patients remained fairly constant during the six months
ended September 30, 2007 and 2006. Based on average revenue for comparable
services from all other payers, revenues foregone under the charity policy,
including indigent care accounts, for the six months ended September 30, 2007
and 2006 were $3.6 million and $4.5 million, respectively.

      Essentially all net operating revenues come from external customers. The
largest payers are the Medicare and Medicaid programs accounting for 66.3% and
68.7% of the net operating revenues for the six months ended September 30, 2007
and 2006, respectively.

      Although not a GAAP measure, the Company defines "Net Collectable
Revenues" as net operating revenues less provision for doubtful accounts. This
eliminates the distortion caused by the changes in patient account
classification. Net Collectable Revenues were $166.6 million and $157.5 million
for the six months ended September 30, 2007 and 2006, respectively, an increase
of $9.1 million, or 6.1% per admission.

OPERATING EXPENSES

      Operating expenses for the six months ended September 30, 2007 increased
to $180.9 million from $179.9 million, an increase of $1.0 million or 0.6%
compared to the same period in 2006. The increase in operating expenses was
primarily the result of the increase in admissions. Operating expenses expressed
as a percentage of revenue for the six months ended September 30, 2007 and 2006
were 99.4% and 102.0%, respectively. The decrease was primarily the result of
improvements in collection of receivables and reduction in the provision for
doubtful accounts.

      Salaries and benefits increased $4.5 million (4.7%) for the six months
ended September 30, 2007 compared to the same period in 2006. Other operating
expenses decreased $1.0 million for the six months ended September 30, 2007
compared to the same period in 2006. The salary and benefits and other operating
expense variances are partially offsetting as the result of bringing dietary
positions in-house and terminating contracts with outside vendors for dietary
services.

      The provision for doubtful accounts for the six months ended September 30,
2007 decreased to $15.6 million from $18.8 million or 17.0% compared to the same
period in 2006. The decrease in the provision for doubtful accounts for the six
months ended September 30, 2007 is primarily due to improvements in recoveries
of bad debt and a reduction in unfunded patients compared to the same period in
2006.

      The loss on sale of accounts receivable for the six months ended September
30, 2007 and 2006 was $5.0 million and $5.0 million, substantially unchanged.

OPERATING INCOME (LOSS)

      Operating income for the six months ended September 30, 2007 was $1.3
million compared to a loss of $3.6 million for the six months ended September
30, 2006. The increase in operating income in 2007 is primarily due to the
increase in revenues.

OTHER EXPENSE, NET

      For the six months ended September 30, 2007 there was no change in the
fair value of warrants. For the six months ended September 30, 2006 there was a
$5.1 million reduction in the fair value of warrants resulting in a gain.

      Interest expense for the six months ended September 30, 2007 was
substantially unchanged compared to the same period in 2006.

NET INCOME (LOSS)

      Net loss for the six months ended September 30, 2007 was $4.6 million
compared to $4.8 million for the same period in 2006.


                                       36




<PAGE>

CASH FLOW

      Net cash used in operating activities for the six months ended September
30, 2007 and 2006 was $11.4 million and $2.0 million, respectively, including
net losses of $3.0 million and $8.1 million, respectively, adjusted for
depreciation and other non-cash items. The Company used $8.4 million and
produced $6.1 million in working capital for the six months ended September 30,
2007 and 2006, respectively. Net cash produced in working capital activities
primarily reflects the increases in accounts payable and accrued liabilities
partially offset by increases in accounts receivable including security reserve
fund and deferred purchase price receivable. Cash produced by growth in accounts
payable, accrued compensation and benefits and other current liabilities was
$6.4 million and $2.4 million, for the six months ended September 30, 2007 and
2006, respectively. Cash provided (used) in accounts receivable, including
security reserve fund and deferred purchase price receivable, was ($8.0) million
and $1.7 million for the six months ended September 30, 2007 and 2006,
respectively.

      Net cash provided by (used in) investing activities during the six months
ended September 30, 2007 and 2006 was $4.6 million and ($164.0) thousand,
respectively. In the six months ended September 30, 2007 and 2006, the Company
invested $372.0 thousand and $164.0 thousand, respectively, in new equipment.
During the six months ended September 30, 2007, $4.9 million in restricted cash
was released to the Company.

      Net cash provided by financing activities for the six months ended
September 30, 2007 and 2006 was $449.0 thousand and $1.8 million, respectively.
The increase in net cash provided by financing activities for the six months
ended September 30, 2006 was primarily represented by $2.0 million in proceeds
from credit facilities.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

      REVENUE RECOGNITION - Net operating revenues are recognized in the period
in which services are performed and are recorded based on established billing
rates (gross charges) less estimated discounts for contractual allowances,
principally for patients covered by Medicare, Medicaid, managed care and other
health plans. Gross charges are retail charges. They are not the same as actual
pricing, and they generally do not reflect what a hospital is ultimately paid
and therefore are not displayed in the condensed consolidated statements of
operations. Hospitals are typically paid amounts that are negotiated with
insurance companies or are set by the government. Gross charges are used to
calculate Medicare outlier payments and to determine certain elements of payment
under managed care contracts (such as stop-loss payments). Because Medicare
requires that a hospital's gross charges be the same for all patients
(regardless of payer category), gross charges are also what Hospitals charge all
other patients prior to the application of discounts and allowances.

      Revenues under the traditional fee-for-service Medicare and Medicaid
programs are based primarily on prospective payment systems. Discounts for
retrospectively cost based revenues and certain other payments, which are based
on the Hospitals' cost reports, are estimated using historical trends and
current factors. Cost report settlements for retrospectively cost-based revenues
under these programs are subject to audit and administrative and judicial
review, which can take several years until final settlement of such matters are
determined and completely resolved. Estimates of settlement receivables or
payables related to a specific year are updated periodically and at year end and
at the time the cost report is filed with the fiscal intermediary. Typically no
further updates are made to the estimates until the final Notice of Program
Reimbursement is received, at which time the cost report for that year has been
audited by the fiscal intermediary. There could be a one to two year time lag
between the submission of a cost report and receipt of the Final Notice of
Program Reimbursement. Since the laws, regulations, instructions and rule
interpretations governing Medicare and Medicaid reimbursement are complex and
change frequently, the estimates recorded by the Hospitals could change by
material amounts. The Company has established settlement payables as of
September 30, 2007 (in thousands) of $305 and receivables as of March 31, 2007
(in thousands) of $909.


                                       37




<PAGE>

      Outlier payments, which were established by Congress as part of the
diagnosis-related groups ("DRG") prospective payment system, are additional
payments made to Hospitals for treating Medicare patients who are costlier to
treat than the average patient in the same DRG. To qualify as a cost outlier, a
hospital's billed (or gross) charges, adjusted to cost, must exceed the payment
rate for the DRG by a fixed threshold established annually by the Centers for
Medicare and Medicaid Services of the United States Department of Health and
Human Services ("CMS"). Under Sections 1886(d) and 1886(g) of the Social
Security Act, CMS must project aggregate annual outlier payments to all
prospective payment system Hospitals to be not less than 5% or more than 6% of
total DRG payments ("Outlier Percentage"). The Outlier Percentage is determined
by dividing total outlier payments by the sum of DRG and outlier payments. CMS
annually adjusts the fixed threshold to bring expected outlier payments within
the mandated limit. A change to the fixed threshold affects total outlier
payments by changing (1) the number of cases that qualify for outlier payments,
and (2) the dollar amount Hospitals receive for those cases that still qualify.
The most recent change to the cost outlier threshold that became effective on
October 1, 2006 was an increase from $23.6 thousand to $24.485 thousand. CMS
projects this will result in an Outlier Percentage that is approximately 5.1% of
total payments. The Medicare fiscal intermediary calculates the cost of a claim
by multiplying the billed charges by the cost-to-charge ratio from the
hospital's most recent filed cost report.

      The Hospitals received new provider numbers in 2005 and, because there was
no specific history, the Hospitals were reimbursed for outliers based on
published statewide averages. If the computed cost exceeds the sum of the DRG
payment plus the fixed threshold, the hospital receives 80% of the difference as
an outlier payment. Medicare has reserved the option of adjusting outlier
payments, through the cost report, to the hospital's actual cost-to-charge
ratio. Upon receipt of the current payment cost-to-charge ratios from the fiscal
intermediary, any variance between current payments and the estimated final
outlier settlement are examined by the Medicare fiscal intermediary. The Company
recorded $755.4 thousand in Final Notice of Program Reimbursement settlements
during the three and six months ended September 30, 2007. There were no
adjustments for Final Notice of Program Reimbursement received during the three
and six months ended September 30, 2006. As of September 30 and March 31, 2007,
the Company recorded reserves for excess outlier payments due to the difference
between the Hospitals actual cost to charge rates and the statewide average in
the amount (in thousands) of $1,598 and $1,831, respectively. These reserves are
combined with third party settlement estimates and are included in due to
government payers as a net payable (in thousands) of $1,903 and $922 as of
September 30, and March 31, 2007, respectively.

      The Hospitals receive supplemental payments from the State of California
to support indigent care (MediCal Disproportionate Share Hospital payments or
"DSH") and from the California Medical Assistance Commission ("CMAC"). The
Hospitals received supplemental payments (in thousands) of $74 and $3,500 during
the three months ended September 30, 2007 and 2006, respectively, and
supplemental payments (in thousands) of $3,828 and $12,136 during the six months
ended September 30, 2007 and 2006, respectively. The related revenue recorded
for the three months ended September 30, 2007 and 2006 was (in thousands) $6,511
and $4,241, respectively, and $10,007 and $11,985 for the six months ended
September 30, 2007 and 2006, respectively. As of September 30 and March 31,
2007, estimated DSH receivables (in thousands) of $7,557 and $1,378 are included
in due from governmental payers in the accompanying condensed consolidated
balance sheets.

      Revenues under managed care plans are based primarily on payment terms
involving predetermined rates per diagnosis, per-diem rates, discounted
fee-for-service rates and/or other similar contractual arrangements. These
revenues are also subject to review and possible audit by the payers. The payers
are billed for patient services on an individual patient basis. An individual
patient's bill is subject to adjustment on a patient-by-patient basis in the
ordinary course of business by the payers following their review and
adjudication of each particular bill. The Hospitals estimate the discounts for
contractual allowances utilizing billing data on an individual patient basis. At
the end of each month, the Hospitals estimate expected reimbursement for
patients of managed care plans based on the applicable contract terms. These
estimates are continuously reviewed for accuracy by taking into consideration
known contract terms as well as payment history. Although the Hospitals do not
separately accumulate and disclose the aggregate amount of adjustments to the
estimated reimbursements for every patient bill, management believes the
estimation and review process allows for timely identification of instances
where such estimates need to be revised. The Company does not believe there were
any adjustments to estimates of individual patient bills that were material to
its net operating revenues.

      The Company is not aware of any material claims, disputes, or unsettled
matters with any payers that would affect revenues that have not been adequately
provided for in the accompanying condensed consolidated financial statements.


                                       38




<PAGE>

      The Hospitals provide charity care to patients whose income level is below
300% of the Federal Poverty Level. Patients with income levels between 300% and
350% of the Federal Poverty Level qualify to pay a discounted rate under AB774
based on various government program reimbursement levels. Patients without
insurance are offered assistance in applying for Medicaid and other programs
they may be eligible for, such as state disability, Victims of Crime, or county
indigent programs. Patient advocates from the Hospitals' Medical Eligibility
Program ("MEP") screen patients in the hospital and determine potential linkage
to financial assistance programs. They also expedite the process of applying for
these government programs. Based on average revenue for comparable services from
all other payers, revenues foregone under the charity policy, including indigent
care accounts, were $2.0 million and $2.0 million for the three months ended
September 30, 2007 and 2006, respectively, and $3.6 million and $4.5 million for
the six months ended September 30, 2007 and 2006, respectively.

      Receivables from patients who are potentially eligible for Medicaid are
classified as Medicaid pending under the MEP, with appropriate contractual
allowances recorded. If the patient does not qualify for Medicaid, the
receivables are reclassified to charity care and written off, or they are
reclassified to self-pay and adjusted to their net realizable value through the
provision for doubtful accounts. Reclassifications of Medicaid pending accounts
to self-pay do not typically have a material impact on the results of operations
as the estimated Medicaid contractual allowances initially recorded are not
materially different than the estimated provision for doubtful accounts recorded
when the accounts are reclassified. All accounts classified as pending Medicaid,
as well as certain other governmental receivables, over the age of 180 days were
fully reserved in contractual allowances as of March 31, 2007. In June 2007, the
Company evaluated its historical experience and changed to a graduated reserve
percentage based on the age of governmental accounts. The impact of the change
was not material.

      PROVISION FOR DOUBTFUL ACCOUNTS - The Company provides for accounts
receivable that could become uncollectible by establishing an allowance to
reduce the carrying value of such receivables to their estimated net realizable
value. The Hospitals estimate this allowance based on the aging of their
accounts receivable, historical collections experience for each type of payer
and other relevant factors. There are various factors that can impact the
collection trends, such as changes in the economy, which in turn have an impact
on unemployment rates and the number of uninsured and underinsured patients,
volume of patients through the emergency department, the increased burden of
co-payments to be made by patients with insurance and business practices related
to collection efforts. These factors continuously change and can have an impact
on collection trends and the estimation process.

      The Company's policy is to attempt to collect amounts due from patients,
including co-payments and deductibles due from patients with insurance, at the
time of service while complying with all federal and state laws and regulations,
including, but not limited to, the Emergency Medical Treatment and Labor Act
("EMTALA"). Generally, as required by EMTALA, patients may not be denied
emergency treatment due to inability to pay. Therefore, until the legally
required medical screening examination is complete and stabilization of the
patient has begun, services are performed prior to the verification of the
patient's insurance, if any. In non-emergency circumstances or for elective
procedures and services, it is the Hospitals' policy, when appropriate, to
verify insurance prior to a patient being treated.

      MEDICAL CLAIMS INCURRED BUT NOT REPORTED - The Company is contracted with
CalOptima, which is a county sponsored entity that operates similarly to an HMO,
to provide health care services to indigent patients at a fixed amount per
enrolled member per month. Through April 2007, the Company received payments
from CalOptima based on a fixed fee multiplied by the number of enrolled members
at the Hospitals ("Capitation Fee"). The Company recognizes these Capitation
Fees as revenues on a monthly basis.

      In certain circumstances, members would receive health care services from
hospitals not owned by the Company. In these cases, the Company records
estimates of patient member claims incurred but not reported ("IBNR") for
services provided by other health care institutions. IBNR claims are estimated
using historical claims patterns, current enrollment trends, hospital
pre-authorizations, member utilization patterns, timeliness of claims
submissions, and other factors. There can, however, be no assurance that the
ultimate liability will not exceed estimates. Adjustments to the estimated IBNR
claims are recorded in the Company's results of operations in the periods when
such amounts are determinable. Per guidance under Statement of Financial
Accounting Standards ("SFAS") No. 5, the Company accrues for IBNR claims when it
is probable that expected future health care costs and maintenance costs under
an existing contract have been incurred and the amount can be reasonably
estimated. The Company records a charge related to these IBNR claims against its
net operating revenues. The Company's net revenues (loss) from CalOptima
capitation, net of third party claims and estimates of IBNR claims, for the
three months ended September 30, 2007 and 2006 were $0.14 million and $(0.67)
million, respectively, and $.19 million and $1.13 million for the six months
ended September 30, 2007 and 2006, respectively. IBNR claims accruals at
September 30 and March 31, 2007 were $2.8 million and $4.1 million,
respectively. The Company's direct cost of providing services to patient members
is included in the Company's normal operating expenses.


                                       39




<PAGE>

      TRANSFERS OF FINANCIAL ASSETS - The Company sells substantially all of its
billed accounts receivable to a financing company (Note 2). The Company accounts
for its sale of accounts receivable in accordance with SFAS No. 140, "Accounting
for Transfers and Servicing of Financial Assets and Extinguishments of
Liabilities - A replacement of SFAS No. 125." A transfer of financial assets in
which the Company has surrendered control over those assets is accounted for as
a sale to the extent that consideration other than beneficial interests in the
transferred assets is received in exchange. Control over transferred assets is
surrendered only if all of the following conditions are met:

      1.    The transferred assets have been isolated from the transferor(i.e.,
            they are beyond the reach of the transferor and its creditors);
      2.    Each transferee has the unconditional right to pledge or exchange
            the transferred assets it received; and
      3.    The Company does not maintain effective control over the transferred
            assets either (a) through an agreement that entitles and obligates
            the transferor to repurchase or redeem the transferred assets before
            their maturity or (b) through the ability to unilaterally cause the
            holder to return specific assets, other than through a cleanup call.

      If a transfer of financial assets does not meet the criteria for a sale as
described above, the Company and transferee account for the transfer as a
secured borrowing with pledge of collateral.

      The following table reconciles accounts receivable at September 30 and
March 31, 2007, as reported, to the pro forma accounts receivable, as if the
Company had deferred recognition of the sales (non GAAP) (in thousands).

<TABLE>
                                                      September 30, 2007                     March 31, 2007
                                              ----------------------------------    ----------------------------------
                                                As reported         Pro Forma         As reported         Pro Forma
                                              ---------------    ---------------    ---------------    ---------------
<S>                                           <C>                <C>                <C>                <C>
Accounts receivable
        Governmental                          $         9,497    $        25,447    $         7,958    $        25,621
        Non-governmental                               13,791             48,977             13,767             51,229
                                              ---------------    ---------------    ---------------    ---------------
                                                       23,288             74,424             21,725             76,850
Less allowance for doubtful accounts                   (1,822)           (18,224)            (2,355)           (16,267)
                                              ---------------    ---------------    ---------------    ---------------
        Net patient accounts receivable                21,466             56,200             19,370             60,583
                                              ---------------    ---------------    ---------------    ---------------
Security reserve funds                                 18,332                  -              7,990                  -
Deferred purchase price receivable                     12,543                  -             16,975                  -
                                              ---------------    ---------------    ---------------    ---------------
        Receivable from Buyer of accounts              30,875                  -             24,965                  -
                                              ---------------    ---------------    ---------------    ---------------
Advance rate amount, net                                    -              7,662                  -             (6,957)
Transaction Fees deducted from Security
        Reserve Funds                                       -            (11,521)                 -             (9,291)
                                              ---------------    ---------------    ---------------    ---------------
                                              $        52,341    $        52,341    $        44,335    $        44,335
                                              ===============    ===============    ===============    ===============
</TABLE>

      Any other term of the APA notwithstanding, the parties agreed as follows:
(a) all accounts derived from any government program payer including, without
limitation, the Medicare, Medi-Cal, or CHAMPUS programs, shall be handled as set
forth in a Deposit Account Security Agreement entered into by the parties, which
provides for the segregation and control of governmental payments by the
Company, (b) the parties agreed to take such further actions and execute such
further agreements as are reasonably necessary to effectuate the purpose of the
APA and to comply with the laws, rules, and regulations of the Medicare and
other government programs regarding the reassignment of claims and payment of
claims to parties other than the provider ("Reassignment Rules"), and (c) until
such time as accounts are delivered by the Company to the Buyer controlled
lockbox, the Company shall at all times have sole dominion and control over all
payments due from any government program payer. The Company believes that the
foregoing method of segregating and controlling payments received from
governmental program payers complies with all applicable Reassignment Rules. As
of September 30, 2007 as shown above as the difference between the accounts
receivable - governmental as reported versus proforma amounts, the Company had
$15,950 thousand in governmental accounts receivable that had been reported as
sold which were subject to the foregoing limitation.


                                       40




<PAGE>

      INSURANCE - The Company accrues for estimated general and professional
liability claims, to the extent not covered by insurance, when they are probable
and reasonably estimable. The Company has purchased as primary coverage a
claims-made form insurance policy for general and professional liability risks.
Estimated losses within general and professional liability retentions from
claims incurred and reported, along with IBNR claims, are accrued based upon
projections determined by an independent actuary and are discounted to their net
present value using a weighted average risk-free discount rate of 5%. To the
extent that subsequent claims information varies from estimates, the liability
is adjusted in the period such information becomes available. As of September 30
and March 31, 2007, the Company had accrued $7.2 million and $4.9 million,
respectively, which is comprised of $1.6 million and $1.4 million, respectively,
in incurred and reported claims, along with $5.6 million and $3.5 million,
respectively, in estimated IBNR.

      The Company has also purchased occurrence coverage insurance to fund its
obligations under its workers' compensation program. The Company has a
"guaranteed cost" policy, under which the carrier pays all workers' compensation
claims, with no deductible or reimbursement required of the Company. The Company
accrues for estimated workers' compensation claims, to the extent not covered by
insurance, when they are probable and reasonably estimable. The ultimate costs
related to this program include expenses for deductible amounts associated with
claims incurred and reported in addition to an accrual for the estimated
expenses incurred in connection with IBNR claims. Claims are accrued based upon
projections determined by an independent actuary and are discounted to their net
present value using a weighted average risk-free discount rate of 5%. To the
extent that subsequent claims information varies from estimates, the liability
is adjusted in the period such information becomes available. As of September 30
and March 31, 2007, the Company had accrued $1.0 million and $1.0 million,
respectively, comprised of $0.3 million and $0.2 million, respectively, in
incurred and reported claims, along with $0.7 million and $0.8 million,
respectively, in estimated IBNR.

      Effective May 1, 2007, the Company initiated a self-insured health
benefits plan for its employees. As a result, the Company has established and
maintains an accrual for IBNR claims arising from self-insured health benefits
provided to employees. The Company's IBNR accrual at September 30, 2007 was
based upon projections determined by an independent actuary. The Company
determines the adequacy of this accrual by evaluating its limited historical
experience and trends related to both health insurance claims and payments,
information provided by its insurance broker and third party administrator and
industry experience and trends. The accrual is an estimate and is subject to
change. Such change could be material to the Company's consolidated financial
statements. As of September 30, 2007, the Company had accrued $1.3 million in
estimated IBNR. The Company believes this is the best estimate of the amount of
IBNR relating to self-insured health benefit claims at September 30, 2007. Since
the Company's self-insured health benefits plan was initiated in May 2007, the
Company has not yet established historical trends which, in the future, may
cause costs to fluctuate with increases or decreases in the average number of
employees, changes in claims experience, and changes in the reporting and
payment processing time for claims.

      The Company has also purchased all risk umbrella liability policies with
aggregate limit of $19.0 million. The umbrella policies provide coverage in
excess of the primary layer and applicable retentions for all of its insured
liability risks, including general and professional liability and the workers'
compensation program.

RECENT ACCOUNTING STANDARDS

      In March 2006, the FASB issued SFAS No. 156, "Accounting for Servicing of
Financial Assets - an amendment of FASB Statement No. 140," with respect to the
accounting for separately recognized servicing assets and servicing liabilities.
SFAS 156 permits the choice of either the amortization method or the fair value
measurement method, with changes in fair value recorded in the consolidated
statement of operations, for the subsequent measurement for each class of
separately recognized servicing assets and servicing liabilities. The statement
is effective for years beginning after September 15, 2006, with earlier adoption
permitted. The adoption of this statement did not have a material impact on the
Company's consolidated financial position and results of operations.

      In September 2006, the FASB issued SFAS No. 157, "Fair Value
Measurements." This Statement establishes a single authoritative definition of
fair value, sets out a framework for measuring fair value, and requires
additional disclosures about fair value measurements. FASB 157 applies only to
fair value measurements that are already required or permitted by other
accounting standards. The statement is effective for financial statements for
fiscal years beginning after November 15, 2007, with earlier adoption permitted.
The Company is evaluating the impact, if any, that the adoption of this
statement will have on its consolidated results of operations and financial
position.


                                       41




<PAGE>

      In February 2007, the FASB issued SFAS No. 159, "The Fair Value Option for
Financial Assets and Financial Liabilities-Including an amendment of FASB
Statement No. 115." SFAS 159 permits entities to choose to measure many
financial instruments and certain other items at fair value. Most of the
provisions of SFAS 159 apply only to entities that elect the fair value option;
however, the amendment to FASB Statement No. 115, "Accounting for Certain
Investments in Debt and Equity Securities," applies to all entities with
available for sale and trading securities. The statement is effective for
financial statements for fiscal years beginning after November 15, 2007. The
Company is evaluating the impact, if any, that the adoption of this statement
will have on its consolidated results of operations and financial position.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

      As of September 30, 2007, we did not have any investment in or outstanding
liabilities under market rate sensitive instruments. We do not enter into
hedging instrument arrangements. On December 12, 2005 we entered into a
derivative financial instrument solely for the purpose of securing a related
loan. This is discussed more fully in the Notes 4 and 5 to the condensed
consolidated financial statements as of and for the three and six months ended
September 30, 2007.

      In determining the fair value of the Deferred Purchase Price Receivable
recorded upon sales of accounts receivable accounts under the Accounts Purchase
Agreement, the key assumption used was the application of a short-term discount
rate. If the discount rate applied increased by 10%, the adverse effect on the
Deferred Purchase Price Receivable and related loss on sale of accounts
receivable would be insignificant.

ITEM 4. CONTROLS AND PROCEDURES.

      The Company maintains disclosure controls and procedures that are designed
to ensure that information required to be disclosed in the Company's Exchange
Act reports is recorded, processed, summarized and reported within the time
periods specified in the SEC's rules and forms, and that such information is
accumulated and communicated to the Company's management, including its Chief
Executive Officer and Chief Financial Officer, as appropriate, to allow timely
decisions regarding required disclosure based closely on the definition of
"disclosure controls and procedures" in Rule 15d-15(e). The Company's disclosure
controls and procedures are designed to provide a reasonable level of assurance
of reaching the Company's desired disclosure control objectives. In designing
and evaluating the disclosure controls and procedures, management recognized
that any controls and procedures, no matter how well designed and operated, can
provide only reasonable assurance of achieving the desired control objectives,
and management necessarily was required to apply its judgment in evaluating the
cost-benefit relationship of possible controls and procedures.

      As of September 30, 2007, the end of the period of this report, the
Company carried out an evaluation, under the supervision and with the
participation of the Company's management, including the Company's Chief
Executive Officer and the Company's Chief Financial Officer, of the
effectiveness of the design and operation of the Company's disclosure controls
and procedures. Based on the foregoing, the Company's Chief Executive Officer
and Chief Financial Officer concluded that the Company's disclosure controls and
procedures were effective.

      Other than as described above, during the quarter ended September 30,
2007, there were no changes in the Company's internal control over financial
reporting that have materially affected, or are reasonably likely to materially
affect, the Company's internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

      We and our subsidiaries are subject to various legal proceedings, most of
which relate to routine matters incidental to operations. The results of these
claims cannot be predicted, and it is possible that the ultimate resolution of
these matters, individually or in the aggregate, may have a material adverse
effect on the Company's business (both in the near and long term), financial
position, results of operations, or cash flows. Although the Company defends
itself vigorously against claims and lawsuits and cooperates with
investigations, these matters (1) could require payment of substantial damages
or amounts in judgments or settlements, which individually or in the aggregate
could exceed amounts, if any, that may be recovered under insurance policies
where coverage applies and is available, (2) cause substantial expenses to be
incurred, (3) require significant time and attention from the Company's
management, and (4) could cause the Company to close or sell the Hospitals or
otherwise modify the way its business is conducted. The Company accrues for
claims and lawsuits when an unfavorable outcome is probable and the amount is
reasonably estimable.


                                       42




<PAGE>

      From time to time, health care facilities receive requests for information
in the form of a subpoena from licensing entities, such as the Medical Board of
California, regarding members of their medical staffs. Also, California state
law mandates that each medical staff is required to perform peer review of its
members. As a result of the performance of such peer reviews, action is
sometimes taken to limit or revoke an individual's medical staff membership and
privileges in order to assure patient safety. In August 2007, the Company
received such a subpoena from the Medical Board of California concerning a
member of the medical staff of one of the Company's facilities. The facility is
in the process of responding to the subpoena and is in the process of reviewing
the matter. Since the matter is in the early stage, the Company is not able to
determine the impact, if any, it may have on the Company's operations or
financial position.

      Approximately 16% of the Company's employees are represented by labor
unions as of September 30, 2007. On December 31, 2006, the Company's collective
bargaining agreements with SEIU and CNA expired. Negotiations with both the SEIU
and CNA led to agreements being reached on May 9, 2007, and October 16, 2007,
for the respective unions. Both contracts were ratified by their respective
memberships. The new SEIU Agreement will run until December 31, 2009, and the
Agreement with the CNA will run until February 28, 2011. Both Agreements have
"no strike" provisions and compensation caps which provide the Company with long
term compensation and workforce stability.

      Both unions filed grievances under the prior collective bargaining
agreements, in connection with allegations the agreements obligated the Company
to contribute to Retiree Medical Benefit Accounts. The Company does not agree
with this interpretation of the agreements but has agreed to submit the matters
to arbitration. Under the new agreements negotiated this year, the Company has
agreed to meet with each Union to discuss how to create a vehicle which would
have the purpose of providing a retiree medical benefit, not to exceed one
percent (1%) of certain employee's payroll. CNA has also filed grievances
related to the administration of increases at one facility, change in pay
practice at one facility and several wrongful terminations. Those grievances are
still pending as of this date, but the Company does not anticipate resolution of
the arbitrations will have a material adverse effect on our results of
operations.

      On May 14, 2007, the Company filed suit in Orange County Superior Court
against three of the six members of its Board of Directors (as then constituted)
and also against the Company's largest shareholder, OC-PIN. The suit sought
damages, injunctive relief and the appointment of a provisional director. Among
other things, the Company alleges the defendants breached fiduciary duties owed
to the Company by putting their own economic interests above those of the
Company, its other shareholders, creditors, employees and the public-at-large.
The suit further alleges the defendants' then threatened attempts to change the
composition of the Company's management and Board (as then constituted)
threatened to trigger multiple "Events of Default" under the express terms of
the Company's existing credit agreements with its secured lenders.

      On May 17, 2007, OC-PIN filed a separate suit against the Company in
Orange County Superior Court. OC-PIN's suit sought injunctive relief and
damages. OC-PIN alleges the management issue referred to above, together with
issues related to monies claimed by OC-PIN, needed to be resolved before
completion of the Company's then pending refinancing of its secured debt. OC-PIN
further alleges that the Company's President failed to call a special
shareholders' meeting, thus denying OC-PIN the opportunity to elect a new member
to the Company's Board of Directors.

      Both actions have since been consolidated before one judge. On July 11,
2007, the Company's motion seeking the appointment of an independent provisional
director to fill a vacant seventh Board seat was granted. On the same date,
OC-PIN's motion for a mandatory injunction forcing the Company's President to
notice a special shareholders meeting was denied. All parties to the litigation
thereafter consented to the Court's appointment of the Hon. Robert C. Jameson,
retired, as a member of the Company's Board.

      The consolidation suits between the Company, on the one hand, and three
members of its former Board and OC-PIN are still pending. Given the favorable
rulings on July 11, 2007 and other factors, the Company continues to prosecute
its original action in hopes of recouping all, or at least a substantial
portion, of the economic losses caused by the defendants' alleged multiple
breaches of fiduciary duty and other wrongful conduct. The Company does not
anticipate the resolution of OC-PIN's ongoing claims for damages will have a
material adverse effect on its results of operations.


                                       43




<PAGE>

      In late May 2007, Western Medical Center, Santa Ana ("Medical Center") was
notified by a May 25, 2007 letter from CMS had identified one case that was a
potential violation of the federal patient anti-dumping law (officially, the
Emergency Medical Treatment and Active Labor Act or EMTALA). In June 2007,
Lumetra, a Medicare quality improvement organization, notified Medical Center
that it was aiding CMS in its investigation of the same matter. Medical Center
has responded to CMS and Lumetra that its actions were appropriate and did not
violate EMTALA. The complaint from CMS and the notice from Lumetra are the first
steps in a determination by the Office of Inspector General ("OIG") of the U.S.
Department of Health and Human Services whether to seek enforcement action for a
violation of EMTALA. The potential sanctions which may be imposed by the OIG for
a violation of EMTALA are a civil money penalty up to $50.0 thousand for a
confirmed violation and possible exclusion from the Medicare and Medi-Cal
Programs. The Company has notified both CMS and Lumetra that it believes that a
violation of the EMTALA statutes and regulations did not occur nor should it be
subject to any civil money penalties. As a prophylactic matter it has also
reviewed and revised its policies and procedures regarding communication and
admission practices through the hospital's emergency department and has
conducted further EMTALA in service training.

ITEM 1A. RISK FACTORS

      There are no material changes from the risk factors previously disclosed
in our Annual Report on Form 10-K for the fiscal year ended March 31, 2007.


                                       44

<PAGE>

ITEM 6. EXHIBITS

Exhibit
Number      Description
------      -----------

10.1        $80,000,000 Credit Agreement (incorporated by reference to Exhibit
            99.1 to the Registrant's Report on Form 8-K filed on October 15,
            2007).
10.2        $45,000,000 Term Note (incorporated by reference to Exhibit 99.2 to
            the Registrant's Report on Form 8-K filed on October 15, 2007).
10.3        $35,000,000 Non Revolving Line of Credit Note (incorporated by
            reference to Exhibit 99.3 to the Registrant's Report on Form 8-K
            filed on October 15, 2007).
10.4        $50,000,000 Revolving Credit Agreement (incorporated by reference to
            Exhibit 99.4 to the Registrant's Report on Form 8-K filed on October
            15, 2007).
10.5        $50,000,000 Revolving Line of Credit Note (incorporated by reference
            to Exhibit 99.5 to the Registrant's Report on Form 8-K filed on
            October 15, 2007).
10.6        $10,700,000 Credit Agreement (incorporated by reference to Exhibit
            99.6 to the Registrant's Report on Form 8-K filed on October 15,
            2007).
10.7        $10,700,000 Convertible Term Note (incorporated by reference to
            Exhibit 99.7 to the Registrant's Report on Form 8-K filed on October
            15, 2007).
10.8        4.95% Common Stock Warrant (incorporated by reference to Exhibit
            99.8 to the Registrant's Report on Form 8-K filed on October 15,
            2007).
10.9        Amendment No. 2 to 31.09% Common Stock Warrant
            (incorporated by reference to Exhibit 99.9 to
            the Registrant's Report on Form 8-K filed on
            October 15, 2007).
10.10       Amended and Restated Triple Net Hospital Building Lease
            (incorporated by reference to Exhibit 99.10 to the Registrant's
            Report on Form 8-K filed on October 15, 2007).
10.11       Settlement Agreement and Mutual Release (incorporated by reference
            to Exhibit 99.11 to the Registrant's Report on Form 8-K filed on
            October 15, 2007).
31.1        Certification of Chief Executive Officer Pursuant to Section 302 of
            the Sarbanes-Oxley Act of 2002
31.2        Certification of Chief Financial Officer Pursuant to Section 302 of
            the Sarbanes-Oxley Act of 2002
32.1        Certification of Chief Executive Officer Pursuant to Section 906 of
            the Sarbanes-Oxley Act of 2002
32.2        Certification of Chief Financial Officer Pursuant to Section 906 of
            the Sarbanes-Oxley Act of 200


                                       45

<PAGE>

                                   SIGNATURES

      In accordance with the requirements of the Securities Exchange Act of
1934, the registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


                                        INTEGRATED HEALTHCARE HOLDINGS, INC.

Dated: November 13, 2007                By: /s/ Steven R. Blake
                                            -------------------
                                            Steven R. Blake
                                            Chief Financial Officer
                                            (Principal Financial Officer)




                                       46